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ERRATUM 
REPORT 2002.014 
CANFAS - Collaborative study for the determination of olaquindox in feedingstuffs by HPLC 
Section 3.1.2 Sample homogeneity 
For both feeds the 'CV (between samples)' of the homogeneity test was calculated erroneously. 
The correct CV (between samples) has to be calculated by multiplying with the result of square 
root of 2. Table 3 must be as follows: 
Table 3: Results of homogeneity tests for olaquindox in piglet feeds 
^ ^ ^ Results 
P roduc t \ ^ ^ 
Piglet feed 
Piglet feed 
Declared 
content 
(mgAg) 
2 
7,5 
Measured 
content 
(mgAg) 
1,5 
4,9 
Homogeneity results 
Between sample 
CV (%) 
3,9 
3,5 
Within sample CV (%) 
2,6 
3,1 
The correction of CV's (between samples) does not influence the conclusion drawn about the 
homogeneity. 
SUMMARY 
This report describes the results of a collaborative study of an HPLC method for the growth 
promoter olaquindox in three piglet feeds. The collaborative study forms part of the EU-project 
"Development and Validation of HPLC-methods for the official control of Coccidiostats and 
Antibiotics used as Feed Additives (CANFAS-SMT4-CT98-2216). 
The principle of the method is as follows: The sample is extracted by a mixture of water -
methanol. The content of olaquindox is determined by reversed-phase high-performance liquid 
chromatography (HPLC) with UV-detection at 380 nm. 
The samples that were tested in the collaborative study were 2 piglet feeds with declared 
olaquindox contents of 2 and 7,5 mgAg and 1 blank piglet feed. The feed samples were sent to 
the participants as blind duplicates. The participants were asked to do duplicate determinations 
per sample. 
Results were reported by 19 laboratories. Statistical evaluation was performed according to ISO 
5725. The results show that acceptable results are obtained for repeatability (rsdr < 10 %) and 
reproducibility (Horrat ratios < 2). However, many laboratories reported difficulties with the 
practicability of the method due to the low ratio between the volume of extraction solvent (50 ml) 
and the weight of feed (25 g). For this reason it is recommended to modify the CANFAS-method in 
such a way that the ratio between the extraction volume and the sample weight is increased to 5 
and to organise a second round of collaborative studies for final validation of the method. 
The results of the collaborative study were evaluated in a meeting attended by the participants. 
It can be concluded that the repeatability and reproducibility of the method is acceptable. The 
results obtained for the blank feed are also acceptable. The panel agreed that, due to the 
problems with the practicability of the method, the method cannot be recommended for adoption 
as an official method. A second collaborative study will be organised with a modified method. 
1 INTRODUCTION 
Within the framework of the EU-project "Development and Validation of HPLC-methods for the 
official control of Coccidiostats and Antibiotics used as Feed Additives (CANFAS-SMT4-CT98-
2216), the official EC-method for olaquindox (Directive 98/64/EC) has been validated for low 
contents in feeds. Olaquindox is a growth promoter that was registered for use in feeds for 
piglets with contents ranging from 15-50 mgAg (50 -100 mgAg for milk replacers). Since 
September 1999, the use of olaquindox as a feed additive is banned in the EU. In order to allow 
adequate control of possible illegal use, the objective was to validate the official EC-method (an 
HPLC method with UV-detection) for contents 5-10 times lower than the lowest content formerly 
permitted, viz. down to 1,5 mgAg. 
The method was validated by LUFA - Augustenberg, Karlsruhe, Germany. Compared with the 
original method, the ratio between the extraction volume and the sample weight was modified: in 
the original method this ratio was 10; in order to increase the limit of detection, in the modified 
method this ratio was decreased to 2 (see report K. Michels, Final report on evaluation of method 
validation for olaquindox and carbadox in feeds at low contents, 01-11-1999). 
Subsequently, the method was subjected to between-lab validation by the State Laboratory, 
Dublin, Ireland (see report P. Shearan, January 2000) and Istituto Superiore di Sanita (I.S.S.), 
Roma, Italy (see report G. Brambilla, January 2000). In general, the criteria as described in the 
amended Project Plan are fulfilled. The recoveries are often lower than 80 % (down to 60 %) but, 
while the use of olaquindox has been forbidden, this is not regarded as a major shortcoming (see 
Second Annual Report CANFAS, J. de Jong, 12-08-2000). 
Prior to the collaborative study, a kick-off meeting was organised (Brussels, 13-14/6/2000) and 
participating laboratories were given the opportunity to familiarise themselves with the method, 
using feed samples with stated contents of olaquindox. Also prior to the production of the 
materials for the collaborative study, separate batches of the materials had been produced for 
homogeneity and stability testing. The between- and within-sample homogeneity was satisfactory 
and the results showed that olaquindox is stable in the feeds at room temperature during a period 
of 4 months. 
The samples that were prepared for the collaborative study were two piglet feeds with declared 
olaquindox contents of 2 and 7,5 mgAg respectively and one blank feed. The feed samples were 
sent to the participants as blind duplicates. Before these samples were shipped, the between- and 
within-sample homogeneity of the feed samples containing olaquindox was checked with 
satisfactory results (see par. 3.1.2). 
Together with the samples, a letter with instructions, reporting forms, etc. was sent to the 
participants (see Appendix 1). 
This report describes the results of the collaborative study. 
2 PARTICIPANTS 
The following laboratories/persons participated in the collaborative study. 
- Administration des Services Technique de l'Agriculture Division des Laboratoires, Ettenbruck, 
Luxemburg; R. Meyers 
- Bundesambt und Forschungszentrum für Landwirtschaft (BFL), Wien, Austria; B. Stoisser, M. 
Wieshaider 
- INETI/DTIA, Lisbon, Portugal; I. Felgueiras, C. Saldanha 
- Istituto Superiore di Sanita, Lab. Med. Veterinaria, Roma, Italy; G. Brambilla, C. Cartoni, M. 
Fiori. 
- Istituto Zooprofilattico Sperimentale della Lombardia e dellémilia Ronagna, Reparto Chimico, 
Brescia, Italy; E. Faggionato, A. Baiguera. 
- Istituto Zooprofilattico Sperimentale della Sardegna, Sassari, Italy; C. Testa, N. Rubattu, A. 
Serra, E. Azara 
- Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy; G. Biancotto, B. Allegretta, 
D. Berto, V. Capuzzo. 
- Istituto Zooprofillatico Sperimentale delle regioni Lazio e Toscana, Roma, Italy; A. Ubaldi, A. di 
Lullo. 
- Laboratoire Inter Régional DGCCRF, Rennes, France; C. Genouel, M.C. Rues, M. Joubert. 
- Laboratório Arbitral Agroalimentario, Madrid, Spain; D.A. Pons, P. Dapena 
- Laboratório Nacional de Sanidad y Produccion Animal - M.A.P.A., Santa Fe, Spain; R. Checa-
Moreno, A. Ariza-Avidad. 
- Laboratory of the Government Chemist, Teddington, United Kingdom; G. Merson, J. Cowles, 
SJayakumar 
- LNIV, Lisbon, Portugal; J.M. Nunes da Costa, M.B. Casqueira. 
- LUFA - Augustenburg, Karslruhe, Germany; K. Michels, S. Witzemann. 
- LUFA-ITL Kiel, Kiel, Germany; F.H. Johannsen, Kollwitz. 
- Masterlab, Putten, The Netherlands; K. van Schalm, A. Schaaf. 
- National Veterinary Institute, Uppsala, Sweden; E. Nordkvist, A. Stepinska 
- Rijksontledingslaboratorium, Tervuren, Belgium; K. Haustraete, A. Fontaine, M. Bral, R. van 
San 
- RIKILT, Wageningen, The Netherlands; H. Kleijnen, H. van der Kamp 
- State Laboratory Dublin, Ireland, P. Shearan, A. Cunningham, A. Murphy 
- Universität Hamburg, Institut für Angewandte Botanik, Hamburg, Germany; H. Putzka, D. 
Böhm. 
- Universität Hohenheim, Landesanstalt für Landwirtschaftliche Chemie, Stuttgart, Germany; B. 
Eckstein, K. Schwadorf, E. Koenzen. 
3 MATERIALS 
3.1 Samples for collaborative study 
3.1.1 Sample composition 
Specifications of the samples, which were produced for the collaborative study, are given in 
Table 1. 
Table 1: Specifications of the samples 
Type of feed 
Piglet feed 
Piglet feed 
Declared 
content 
2 
7,5 
Units 
mgAg 
mgAg 
Subcontractor 
IPC - Dier, Barneveld 
(NL) 
IPC - Dier, Barneveld 
(NL) 
Date of 
production 
05/09/2000 
05/09/2000 
The feed sample with 2 mgAg olaquindox also contained 10 mg/kg carbadox, the feed sample 
with 7,5 mgAg olaquindox also contained 2,5 mgAg carbadox. The complete composition of 
the feeds is given in Appendix 2 (in Dutch). The main composition of the two feeds is given in 
Table 2. 
Table 2: Main composition of the two feeds 
" ~ " - \ ^ ^ Product 
l n g r e d i e r u ^ \ ^ ^ 
Crude protein (%) 
Crude fat (%) 
Starch (%) 
Crude fibre (%) 
Crude ash (%) 
Moisture (%) 
Piglet feed 
18,1 
4,3 
39,4 
4,4 
4,7 
12,4 
The composition of the feeds was the same as the composition of the products which were 
produced by IPC-Dier in September 1999 for stability testing (see Report on homogeneity and 
stability studies of samples for the collaborative studies for olaquindox, K. Michels, LUFA 
Augustenberg, Germany, 05/05/2000). 
The feed products have been prepared in a quantity of 500 kg each. To achieve a maximum 
degree of homogeneity halfway through the production 54 kg of feed are withdrawn from the 
stream for subsampling activities and put into three sacks of 18 kg. After discarding the top 
layer (ca. 2 kg) about 30 - 50 subsamples of approx. 250 grams have been taken (manual 
distribution with a shovel) from each of these sacks. The subsamples were stored in double 
paper sacks. 
All subsamples have been stored at room temperature (ca. 20 °C). 
Next to the above mentioned samples that contained olaquindox, a blind blank feed was sent to 
the participants as well as a blank feed labelled "blank feed for olaquindox recovery purposes" 
(see Appendix 1). The blind blank feed was a bull feed containing 5 mgAg virginiamycin (see the 
corresponding CANFAS report). This feed was analysed at LUFA Augustenberg prior to the 
collaborative studies and was found to contain a small interfering peak at the retention time of 
olaquindox which corresponds to ca. 0,5 mgAg- The blank feed for olaquindox recovery 
purpose was a standard piglet feed produced by IPC-Dier. This feed was also analysed prior to 
the collaborative study and contained no detectable amounts of olaquindox or interfering 
substances. 
3.1.2 Sample homogeneity 
The homogeneity of the samples was studied by LUFA Augustenberg by random selection of 10 
subsamples, applying the HPLC-method developed in CANFAS (see Annex 1 of Appendix 1). 
The results of the homogeneity determinations of the individual feeds are attached in Appendix 
3. Table 3 gives a summary of these results. 
Table 3: Results of homogeneity tests for olaquindox in piglet feeds 
^Results 
Product \ ^ 
Piglet feed 
Piglet feed 
Declared 
content 
(mgAg) 
2 
7,5 
Measured 
content 
(mgAg) 
1,5 
4,9 
Homogeneity results 
Between sample 
CV (%) 
2,8 
2,5 
Within sample CV (%) 
2,6 
3,1 
According to the Project Plan the CV's for homogeneity should not exceed 2 times the CVs for 
repeatability (CVhom < 2 CVr). Based on previous results of within-lab validation (see Second 
Annual Report CANFAS, J. de Jong, 12-08-2000) the maximum limit for CVhom was set to 16 %. 
All between- and within-sample CV's fulfil these requirements. Thus, it is concluded that the 
samples are sufficiently homogeneous. 
3.1.3 Sample logistics 
The samples were sent as blind duplicates. The codes are given in Appendix 4. The samples 
were sent to the participants by courier service on 2 October 2000 together with a letter with 
instructions (Appendix 1). During transport no special precautions were taken with regards to the 
temperature of the samples. 
3.2 Reference standard 
The reference standard was supplied by Dr. A. Ploger, Danish Plant Directorate, Lyngby (DK). 
According to the specifications (see Appendix 5), the purity of the reference standard (Lot Nr. 
890416) is 99,46 %. The participants were instructed to set the purity of the reference standard 
to 100% (see Appendix 1). 
The expiration date of the reference standard was April 2001. The identity and content was 
checked by RIKILT. The identity could be confirmed by UV, ^-NMR as well as mass spectrometry. 
The purity was determined by ^-NMR and UV spectroscopy and was shown to be approx. 100 % 
(see Appendix 5). 
4 METHODS 
4.1 Method of analysis 
The method of analysis is included as annex 1 to Appendix 1. The participants were instructed 
that this method has to be used without any modifications. 
4.1.1 HPLC-conditions 
Various types of HPLC-columns were used (the column which was recommended in the method 
is a C18, 250 mm x 4 mm, 5 urn packing or equivalent). 
The mobile phase described in the method is a mixture of water and methanol 900:100 (v/v). 
Three laboratories used a different mobile phase. 
The HPLC conditions (Column and mobile phase) used by the participants are shown in Table 4. 
4.2 Method for statistical evaluation 
Statistical evaluation was performed according to ISO 5725 Part 2: Basic method for the 
determination of repeatability and reproducibility of a standard measurement method (First 
edition, 1994-12-15). 
The scrutinity of results for consistency and outliers was checked by 
Graphical consistency techniques: Mandel's h plot for between-laboratory variability, Mandel's k 
plot for within-laboratory variability 
Numerical outlier techniques: Cochran's test of the within-laboratory variability, Grubbs' test (single 
and double) for between-laboratory variability 
Whenever necessary and appropriate, laboratories which showed consistently high within-cell 
variation and/or extreme cell means across many levels and/or Cochran or Grubbs' outliers were 
contacted to try to ascertain the cause of the discrepant behaviour. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility of the method. The HORRAT ratios are given in Table 5. The HORRAT ratios should 
be lower than 2 (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). 
10 
Table 4: HPLC-conditions 
Partner 
12 
15 
16 
17 
18 
20 
21 
23 
24 
25 
26 
27 
29 
31 
32 
33 
34 
37 
38 
40 
Column 
As described in the method 
Hypersil ODS 5 urn 200 x 4,6 mm + 
guard column 
Sperisorb ODS 2, 10 urn 
250 x 4,6 mm 
Sperisorb SI0ODS-1 10 u 
150 x 4,6 mm; 5 urn; Sperisorb 
0DS2 C18 
Alltimo Alltech C18, 250x4,6 mm, 5 
urn 
Supelcosil LC-18 25 cm x 4,6 mm (5 
urn) + supelguard LC-18 
Not reported 
250 x 4,6 mm C18 5 urn 
As described in the method 
Sperisorb ODS 2 250 mm x 4,6 mm 
5 urn 
As described in the method 
Nova Pack, 4,6 x 250 mm; C18; 4 u 
As described in the method 
Waters symmetry, CI8, 5um, 
4,6x250 mm 
As described in the method 
As described in the method, 
üchrosper RP18-5 endcapped 
Hypersil ODS C-18, 250 x 4,6 mm, 5 
urn 
C18 sperical 5 urn 3,9 x 15 cm 
waters 
Mobile phase 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
Acetonitril: ammoniumacetate buffer (0,01 M; 
pH 4,6) Gradient elution 
As described in the method 
Water/methanol = 800:200 (v/v) 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
0,01 M ammoniumacetate pH 5: acetonitrile 
= 95:5 (v/v) 
As described in the method 
As described in the method 
As described in the method 
As described in the method 
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5 RESULTS 
For each participant the reported results for the samples, the completed questionnaire and 
representative chromatograms are annexed in Appendix 6. 
5.1 Statistical evaluation 
The results reported by the participants are given in Table 6. 
Due to problems in obtaining enough solvent after the extraction step two laboratories used a 
modified method with a higher ratio between extraction volume and sample weight. The results of 
these laboratories are not included in Table 6 and will be described in par. 5.5. 
The results reported by lab 25 clearly show that this lab has interchanged (the results of) the 
samples (see also par. 5.2): two samples are reported as "nd", two samples at 1,70 mg/kg and 
two samples at 4,86 - 4,88 mgAg but only in one case the code corresponds to the right 
sample. This lab was contacted but was not able to trace back the origin of the interchange. For 
this reason the results of lab 25 were not taken into account in the statistical evaluation. 
Statistical analysis shows that the results of the other laboratories do not contain Cochran or 
Grubbs' outliers or stragglers. The values for the statistical parameters (mean, relative standard 
deviations for repeatability and reproducibility) are given in Table 6. According to the Project Plan, 
the rsdr-values should be < 10 %. For both samples this criterion is met and consequently it can 
be concluded that the repeatability is satisfactory. 
The Horwitz equation and the HORRAT ratios form the basis for the evaluation of the 
reproducibility (see W. Horwitz and R. Albert, J.A.O.A.C. 74 (1991) 718-744). The HORRAT ratios 
are given in Table 5. The HORRAT ratios should be lower than 2. For both samples this criterion is 
met and established rsdR-values are in line with values predicted by the Horwitz equation. 
Consequently it can be concluded that the reproducibility of the method is satisfactory. 
Table 5: Horrat ratios of the olaquindox collaborative study 
Mean after discarding 
lab 25 (mgAg) 
1,721 
5,284 
Predicted 
rsdR 
14,745 
12,454 
Established 
rsdR 
21,12 
16,65 
Horrat1 
1,43 
1,34 
Conclusion 
Reproducibility OK 
Reproducibility OK 
1
 = Horrat is the ratio between the established rsdR and the predicted rsdR 
The Mandel h and k plots are shown in Figure 1. The Mandel h plot shows that 3 laboratories (nr. 
15, 29 and 37) reported low values for both samples. Laboratories 29 and 37 reported the 
lowest recoveries, viz. 69 and 49 % while the recovery reported by lab 15 (78 %) is a normal 
value. Lab 37 is considered as a Grubbs outlier with regard to the recovery (see par. 5.3). 
Nevertheless it is unjustified to discard the results of lab 37 from statistical evaluation because of 
the problems encountered by many laboratories (among them lab 37, see par. 5.4) with the 
extraction step in the method, which is regarded as the main causative factor for the low 
recovery. 
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Table 6: Results reported by the participants. 
Table 6. Olaquindox in two piglet feeds 
Sample 
Lab 
12 
15 
16 
17 
18 
20 
21 
23 
24 
25 
26 
27 
29 
31 
32 
33 
34 
37 
38 
40 
Result (mg/kg) 
OLA 
2 mg/kg 
1,97 
1,25 
1,56 
2,07 
1,56 
1,72 
2,00 
1,67 
2,00 
nd 
1,60 
2,05 
1,20 
1,88 
2,06 
2,30 
1,50 
1,38 
1.72 
1,50 
OLA 
2 mg/kg 
2,01 
1,02 
1,70 
1,99 
1,52 
1,60 
2,00 
1,76 
2,10 
nd 
1,50 
1,98 
1,30 
1,90 
2,24 
2,40 
1,50 
1,22 
1,76 
1,80 
OLA 
2 mg/kg 
1,54 
1,12 
1,66 
1,99 
1,67 
1,52 
2,00 
1,91 
1,80 
nd 
0,70 
1,81 
1,30 
2,08 
2,07 
2,50 
1,50 
1,11 
2,01 
2,21 
OLA 
2 mg/kg 
1,51 
1,34 
1,65 
1,92 
1,65 
1,59 
2,00 
1,86 
1,70 
nd 
1,20 
1,89 
1,30 
1,80 
2,03 
2,50 
1,50 
1,02 
1,94 
1,62 
OLA 
7,5 mg/kg 
4,84 
4,60 
5,66 
5,60 
5,78 
4,85 
5,40 
4,23 
5,70 
4,88 
5,10 
5,22 
3,80 
6,28 
5,91 
7,40 
4,70 
3,70 
6,00 
4,75 
OLA 
7,5 mg/kg 
4,78 
3,52 
4,98 
5,66 
5,92 
4,78 
5,30 
5,77 
6,20 
4,88 
4,80 
5,34 
3,70 
6,13 
5,92 
6,90 
4,80 
3,63 
5,52 
4,56 
OLA 
7,5 mg/kg 
5,84 
4,14 
5,65 
5,58 
6,18 
4,65 
5,30 
5,40 
6,00 
1J0 
6,00 
5,30 
3,80 
6,05 
5,63 
7,20 
4,80 
3,50 
5,53 
5,20 
OLA 
7,5 mg/kg 
5,85 
4,76 
5,54 
5,63 
6,12 
4,78 
5,20 
5,37 
5,90 
1J0 
5,30 
5,56 
3,70 
5,86 
5,71 
7,20 
4,90 
3,58 
5,38 
5,74 
number of labs 
m (mg/kg) 
rsdr(%) 
rsdR (%) 
19 
1,721 
9,47 
21,1 
19 
5,284 
6,22 
16,6 
Remark : Italic printed results are not taken into account in the statistical evaluation! 
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Figure 1: Mandel h and k plots of results reported by the participants. 
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5.2 Blank samples 
Table 7: Reported results of the blank samples 
Partner 
12 
15 
16 
17 
18 
20 
21 
23 
24 
25 
26 
27 
29 
31 
32 
33 
34 
37 
38 
40 
Blank sample 1 
Result 1 
Nsd 
Blank 
Not found 
-
Not detected <0,5 
Neg 
0,0 ND 
<0,11 
Blank 
1,70 
0,1 
Not detect. 
0 
0 
Negative 
<1 
0 
ND 
0 
-
Result 2 
nsd 
blank 
Not found 
-
Not detected <0,5 
Neg 
0,0 ND 
<0,21 
blank 
1,70 
0,1 
Not detect. 
0 
0 
negative 
<1 
0 
ND 
0 
Not analysed 
Blank sample 2 
Result 1 
Nsd 
Blank 
Not found 
-
Not detected <0,5 
Neg 
0,0 ND 
<0,11 
Blank 
4,88 
0,1 
Not detect. 
0 
0 
Negative 
<1 
0 
ND 
0 
-
Result 2 
Nsd 
Blank 
Not found 
-
Not detected <0,5 
Neg 
0,0 ND 
<0,21 
Blank 
4,86 
0,1 
Not detect. 
0 
0 
Negative 
<1 
0 
ND 
0 
Not analysed 
Only laboratories 25 and 26 reported positive results for the blank samples. For lab 25 this was 
caused by the fact that this lab had interchanged the samples (see par. 5.1). 
For lab 26 the reported values (0,1 mgAg) are at the limit of detection defined for the method. 
Consequently it can be concluded that no interfering substances are detected in the blank 
samples. 
15 
5.3 Recoveries 
Table 8: Recoveries 
Partner 
12 
15 
16 
17 
18 
20 
21 
23 
24 
25 
26 
27 
29 
31 
32 
33 
34 
37 
38 
40 
Recovery 1 in % 
78 
78 
77 
85 
80 
101 
83 
Not reported 
71 
84 
75 
76 
68 
78 
82 
93 
82 
48 
81 
83 
Recovery 2 in % 
76 
83 
76 
101 
84 
86 
71 
70 
86 
87 
91 
86 
49 
Average recovery in (%) 
78 
78 
77 
84 
78 
101 
84 
79 
84 
73 
76 
69 
82 
85 
92 
84 
49 
81 
83 
Recoveries range from 48-101 %. This range is broader than the range (60 - 90 %) which was 
measured in the between-lab validation of the method (see Second Annual Report CANFAS, J. de 
Jong, 12-08-2000). 
Most probably, the problems encountered by many laboratories with the extraction step in the 
method are the main causative factor for the low recovery. 
The mean recovery value reported by lab 37 (49 %) is a Grubbs outlier. 
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5.4 Remarks 
Table 9: Remarks made by the partners 
Partner Remarks 
12 In some cases (we try the method as well with real samples of feedingstuffs), the 
volume of liquid for the extraction is not enough to get a proper volume of 
extractant solution, even with centrifugation. We think the weight/volume could be 
1/3, not Vz. 
Perhaps, this is one of the reasons because of the revovery percentages are not so 
good as with carbadox method (where the relation is 1/5). 
15 We have encountered some troubles performing the centrifugation step of 50 ml 
solvent extract in the extraction procedure. However the results were obtained 
utilising the method without modification. 
In another occasion, we have tried to increase extraction volume to 100 ml (20 ml 
methanol and 80 ml water) obtaining an increase of recovery from 78% to 88% at 
3,0 mg/kg spiking level and the following results on the samples: 
Sample code Result 1 (mg/kg) Result 2 (mg/kg) 
155711 
155735 
155741 
155761 
155776 
155784 
blank 
2,07 
1,92 
blank 
5,90 
5,95 
blank 
1,91 
2,09 
blank 
5,86 
6,02 
spike 3,0 mg/kg 2,67 (rec 89%) 2,66 (rec 89%) 
16 1. 5.1.2 Recovery test: "..Proceeding with the extraction step (5.2)". 
Remark: Transfer of 1,5 ml stock standard solution (3.5.1) results in our opinion in 
the addition of 38,5 ml water and not in 40 ml water (see 5.2). This volume error 
amounts to about 3 %. 
2. 5.2 Extraction: 
Remark: weight in of 25 g of sample in relation with a volume of 50 ml of liquid 
strongly recommends centrifugation. 
Our parameters: 10 minutes with 7200 rpm. The supernatant liquids were 
subsequently filtered by using membrane filters (Macherey&Nagel, Chromafil Type A-
45/25, 0,45 urn). 
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Partner 
17 
18 
20 
21 
Remarks 
Ad 3.5.1 The olaquindox-standard is soluble within 1 minute by ultrasonic treatment. 
An ultrasonic treatment of 10 minutes warms up the fluid. 
Ad. 5.2.1 Attention: the total volume by the recovery test is 51,5 ml!! 
Ad. 5.2 a) It is hardly possible too moisten 25 g sample with 10 ml methanol. 
b) It is hardly possible to shake or stir the sample (25g/50 ml liquor) 
c) It is better to centrifuge the sample than to filter through an folded filter (suck up 
of the liquid). 
All samples were analysed by the existing EU-Methode 98/64 
mgAg recovery % 
175703 - +3mgolaquAg: 88% 
175718 6,09 
175730 2,10 
175775 - +6mgolaquAg: 88% 
175817 2,14 
175828 6,21 
HPLC equipment: 15 and 16/11/00: pump; autosampler->HP 1050 (40 ul); DAD-> 
HP 1100 
23/11/00: pump Spectra Physics; autosampler Marathon (50 ul); single wave 
length Milton Roy; Chromjet Recorder 
Differences with CANFAS/ola/02/10/2000 method: 
- 3.5,1 Stock standard solution -> 50 mg/1000 ml; weigh to the nearest 1 mg 
- 3JL2 Standard solutions -> point at 2,5 ug/ml -> 5 ml of (3.5.1) in a 100 ml 
graduated flask. 
- 5J> Instead of filtration through a folded filter, centrifugation was carried out as 
mentioned at 7.1. 
- Receival of sample package on 5/10/00, storage of samples until analysis at < 
8 °C, in a refrigerated room 
- 15 and 16/11/2000: direct analysis of the 6 feeds with DAD; test of recovery; 
identity confirmation 
- 23/11/2000: Analysis, with single wavelength detector, of the 2 blank feeds 
and the lowest content sample to estimate LOD and LOQ 
Results; 
- Reported results are the average of height and area results. 
- Calibration based on height and area (10 points; forced through origin) -> see 
example 
No remarks 
We found difficulties during the extraction because of the large amount of the feed 
compared to the volume of the solvent. 
In two samples (n. 770-791) the solvent was almost completely absorbed by the 
feed and this made the extraction of the samples very difficult. We were forced to 
centrifuge these extracts in order to obtain supernatant. 
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Partner 
23 
24 
25 
26 
27 
29 
31 
32 
33 
34 
37 
38 
40 
Remarks 
Not reported 
The ratio between the sample amount and the extraction solvent volume resulted to 
be a very critical step of the method which could affect the reproducibility. 
We had some difficulties in the extraction method (5.2). It was very difficult to have 
enough filtrate in the filtration step so centrifugation has been applied (4000 rpm for 
15 min.) 
Then we followed the standard procedure: 
Transfer the sample extract in a 50 ml volumetric flask 
Filter the solution trough a folded filter 
Filter an aliquot through a membrane filter (0,45 urn) for analysis by HPLC 
No remarks 
As to the samples with the code numbers 275720 and 275773 strong swelling 
avoided a shakeable suspension to be formed. Along with 275720 the lot of fluid 
was enlarged to 70 ml„ along with 275773 the volume of extraction fluid was 
doubled; in this case the injection volume was doubled as well as that of the 
calibration standards so that the limit of detection (with 0,1 mg/kg) could be 
ensured. 
No remarks 
During HPLC-analyses the area/height ratio changed, the peaks got broader. 
Quantification was only possible on area. 
Sample preparation: 
The samples were centrifuged after extraction, then filtrated on GFA-filter, followed 
by filtration on acrodisc 0,45 urn 
No remarks 
No remarks 
No remarks 
We found it impossible to proceed with the method particularly with the use of 
conical flask + filtration of sample. In this situation no filtrate was collected. 
The entire study was done using 150 ml glass centrifuge tubes (instead of conical 
flasks) with a centrifugation step (15 min at 3000) (instead of filtration). It was also 
necessary to further separate the filtrate and centrifuge this prior to HPLC. 
Please note that our detection system has been DAD; not a single wavelength UV-
detection (as it has been indicated at particularly instruction) because we have not 
it. 
No remarks 
The remarks clearly indicate that the practicability of the method is unsatisfactory. Ten out of 
nineteen laboratories reported difficulties in obtaining enough solvent after the extraction step due 
to the low ratio between the volume of solvent (50 ml) and the weight of feed (25 g). Moreover, 
two laboratories decided to use a modified method with a higher ratio between extraction volume 
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and sample weight (see par. 5.5) and one laboratory informed the coordinator that they abstained 
from participation due to the same problem. 
The results of laboratories 15 and 17 show that when the ratio between the extraction volume and 
the sample weight is increased, the recoveries increase and the values for the blind positive 
samples are higher than with the CANFAS-method. 
For these reasons it is proposed to modify the CANFAS-method in such a way that the ratio 
between the extraction volume and the sample weight is increased to 5 and to organise a second 
round of collaborative studies for final validation of the method. 
5.5 Special requests 
The following participants used divergent extraction volumes and/or sample weights, because of 
difficulties with the prescribed ratio of extraction volume and sample weight (strong swelling, not 
possible to shake). See also paragraph 5.5.3, remarks. 
- Masterlab, Putten, The Netherlands; K. van Schalm, A. Schaaf. 
- National Veterinary Institute, Uppsala, Sweden; E. Nordkvist, A. Stepinska 
5.5.1 H PLC conditions 
Table 10: HPLC conditions 
Partner 
Masterlab, Putten, The 
Netherlands 
National Veterinary Institute, 
Uppsala, Sweden 
Column 
As described in the 
method. 
Hypersil C18 ODS BDS 
250 x 4,6 mm; 5 urn 
Mobile phase 
As described in the method 
As described in the method 
5.5.2 Recoveries 
Table 11: Recoveries 
Partner 
Masterlab, Putten, The 
Netherlands 
National Veterinary Institute, 
Uppsala, Sweden 
Recovery 1 in % 
98 
95 
Recovery 2 in % 
82 
96 
Recovery average in % 
90 
96 
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5.5.3 Remarks 
Table 12: Remarks made by the partners 
Partner 
Masterlab, Putten, The 
Netherlands 
National Veterinary 
Institute, Uppsala, Sweden 
Remarks 
As prescribed in the method 25 gram sample was mixed with 10 
ml methanol and 40 ml water. The whole volume was absorbed 
by the sample and as a results it was not possible to shake the 
extract. An extra volume of 10 ml methanol and 40 ml water was 
added. This extract remained a thick pulp, but it could be shaken. 
The extract was centrifuged prior to filtration over GF/A. 
1. Since the volume extraction solution (50 ml) was found too 
small for extracting the 25 g sample, a 10 g sample was used for 
the extraction of olaquindox. 
2. The UV-detector wavelength used was 372 nm instead of the 
recommended 380 nm ( the absorbance maximum was detected 
at this wavelength. 
3. The olaquindox content was calculated from the peak area by 
reference to the calibration graph. 
5.5.4 Results of the samples 
Table 13: Results reported by the partners 
Partner 
Sample 
content 
(mgAg) 
0 
0 
2 
2 
7,5 
7,5 
Masterlab, Putten, The Netherlands 
Result 1 
(mgAg) 
<0,1 
<0,1 
1,5 
1,6 
4,6 
6,2 
Result 2 
(mgAg) 
<0,1 
<0,1 
1,4 
1,5 
4,5 
6,3 
National Veterinary Institute, Uppsala, 
Sweden 
Result 1 
(mgAg) 
<1 
<1 
2,27 
2,34 
6,93 
6,81 
Result 2 
(mgAg) 
<1 
<1 
2,2 
2,21 
7,05 
6,79 
The values of Masterlab are similar to the mean values obtained with the CANFAS method. The 
values of National Veterinary Institute are higher than the mean values obtained with the CANFAS 
method. Again this shows the applicability of a higher ration between extraction volume and 
sample weight. 
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6 EVALUATION AND CONCLUSIONS 
The results of the collaborative study were evaluated in a meeting in Tervuren (Belgium) on June 
19-20,2001. 
The panel has accepted the results of the statistical evaluation, as described in par. 5.1, Table 6. 
Consequently it can be concluded that the repeatability and reproducibility of the method is 
acceptable. The results obtained for the blank feed are also acceptable. Large differences are 
observed in the recovery (range 49 - 101 %), most probably due to the problems in the 
extraction step, caused by the unfavourable ratio between extraction volume and sample weight. 
The panel agreed that, due to the problems with the practicability of the method (see par. 5.4), 
the method cannot be recommended for adoption as an official method. A second collaborative 
study will be organised with a modified method. The ratio between the extraction volume and the 
feed weight will be increased from 2 : 1 to 5 : 1 . 
The results obtained for the blind blank feed indicate that different columns lead to differences in 
interfering peaks (large peak eluting prior to olaquindox). 
The following columns will be recommended in the method: 
- Hypersil ODS 5 urn, 200 x 4,6 mm; 
- Spherisorb ODS-2 5 urn, 250x4,6 mm; 
- LUNA C18(2) 250x4,6 mm. 
The following remarks, related to the method description have been accepted: 
- Lab 16, remark 1 (see par. 5.4 of this report). 
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APPENDIX 1 
Letter with instructions, sent with the samples (with four annexes) 
cc Driessen/J. de Jon. 
Dear colleague, 
Please find enclosed the samples for the collaborative study for olaquindox: 
• 6 feed samples, with the text "additive: OLAQUINDOX" and with a sample code; 
these samples constitute 2 blind duplicates of feed samples containing olaquindox 
(contents In the range between 1 and 15 mg/kg) and 1 blind duplicate of a blank 
feed 
The samples must be analysed in duplicate. 
DATE 
2 October 2000 
SUBJECT 
collaborative «Uidy CANFAS 
olaquindox 71.316.24 
ENCLOSUREtSI 
4 
OUR REFERENCE 
00/0022094 
HANDLED BY 
Dr. J. da Jong 
DIRECT (TELEPHONE] LINE 
•31 317 47 55 81 
E-MAIL 
i.dejongeRIKILT.WAG-UR.nl 
For recovery purposes we have included a blank sample, with the text "blank feed for 
olaquindox recovery purposes". 
The method which has to be used is included as Annex 1 (please note that this method is 
a modified version of the method which was distributed prior to the kick-off meeting). 
Annex 2 contains the reporting form. This form will also be send to you by E-mail as an 
Excel 5.0 file. We strongly prefer to get the results back in electronic form by E-mail 
(please send the results to the following E-mail address: j.j.m.driessen@rikilt.wag-ur.nl). 
Of course you can also fill in the form and send it by fax or normal mail. 
The deadline for reporting the results is 8 December 2000. 
RIKILT 
State Institute (or Quality 
Control of Agricultural 
Product« 
P.O.Box 230 
6700 AB Wageningen 
The Netherlands 
VISITORS' ADDRESS 
Building no. 123 
Bornseeteeg 45 
6708 PD Wageningen 
TELEPHONE 
+31 317 47 54 00 
Annex 3 contains instructions for handling (milling, storage) of the samples. 
Annex 4 is a questionnaire. We kindly ask you to give us information about the 
experimental conditions, recoveries, etc.. On this form you can also give your remarks 
about the method. 
«31 317 41 77 17 
CHAMBER OF COMMERCE REGISTRATION NO. 
09098104 te Arnhem 
THE INTERNET 
«nww.rikilt.wageningen-ur.nl 
The reference standard of olaquindox which has to be used (980416) was already sent 
to you with my letter of 31 May 2000. In the calculations this reference standard can be 
regarded as 100 % pure. 
We wish you and your colleagues the best with the collaborative studies. If you have any 
questions, do not hesitate to contact us. 
Kind regards, 
dr. Jacob de Jong ing. J.J.M. Driessen 
CANFAS coordinator co-ordinator CANFAS 
collaborative studies 
RIKILT 
Stat* Institute for Quality C 
of Agricultural Producta 
DATE 
2 October 2000 
OUR REFERENCE 
00/0022094 
PAGE 
2 of 2 
cc mrs. I. de Froidmont-Görtz, European Commission, DG Research, CII/3, Brussels 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 1 - Description of the method 
CANFAS/OLA/02102000/K.MICHELS 
SMT4-CT98-2216 
Determination of low level contents of Olaquindox in Feedingstuffs 
1. Purpose and scope 
The method is for the determination of olaquindox in feedingstuffs. The limit of 
determination (=quantification) is 1,5 mg/kg. The limit of detection («qualification) is 
0,1 mg/kg 
2. Principle 
The sample is extracted by a water methanol mixture. The content of olaquindox is 
determined by reversed-phase high-performance liquid chromatography (HPLC) 
using an UV detector. 
3. Reagents 
3.1. Methanol 
3.2. Methanol, HPLC grade 
3.3 Water, HPLC grade 
3.4. Mobile phase for HPLC 
Water (3.3)-methanol (3.2) mixture, 900+100 (V + V) 
3.5. Standard substance: pure olaquindox 2-[N-2'-(hydrxyethyl)carbamoyl]-3-
methylquinoxaline-N1 .N^-dioxide, E 851 
3.5.1. Olaquindox stock standard solution, 50 ug/ml 
Weigh to the nearest 0,1 mg 10 mg of olaquindox (3.5) in a 200 ml graduated flask 
and add ca. 190 ml water. Then place the flask for 10 min in a ultrasonic bath (4.1). 
After ultrasonic treatment, bring the solution to room temperature, make up to the 
mark with water and mix. Wrap the flask with aluminium foil and store in a refrigerator. 
At this temperature of £ 4°C the solution is stable for 1 month. 
3.5.2. Calibration solutions 
Into a series of 50 ml graduated flasks transfer 0.5,1.0, 2.5, 5.0 and 10.0 ml of the 
standard stock solution (3.5.1). Make up to the mark with water (3.3) and mix. These 
solutions correspond to 0.5, 1.0, 2.5, 5.0 and 10.0 ug of olaquindox per ml 
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respectively. 
These solutions must be prepared fresh each day. 
4. Apparatus 
4.1. Ultrasonic bath 
4.2. Mechanical shaker 
4.3. Membrane filter, 0.45 um 
4.4. HPLC equipment with variable wavelength ultraviolet detector 
4.4.1. Liquid chromatographic column, 250 mmx4mm, C 18, 5 urn packing, or equivalent 
5. Procedure 
Note: Olaquindox is light sensitive. Cany out all procedures under subdued light or 
use amber glass ware. 
5.1. General 
5.1.1. Blank feed 
For the perfomance of the recovery test (5.1.2) a blank feed should be analysed to 
check that neither olaquindox nor interfering substances are present. The blank feed 
should be similar in type to that of the sample and on analysis olaquindox or 
interfering substances should not be detected. 
5.1.2. Recovery test 
A recovery test should be carried out by analysing the blank feed which has been . 
fortified by addition of a quantity of olaquindox, similar to that present in the sample. 
To fortify at a level of 3 mg/kg, transfer 1.5 ml of the stock standard solution (3.5.1) to 
a 250 ml conical flask, add 25 g of the blank feed, mix thoroughly and leave for 10 
min mixing again several times before proceeding with the extraction step (5.2). 
Alternatively, if a blank feed similar in type to that of the sample is not available (see 
5.1.1), a recovery test can be performed by means of the standard addition method. 
In this case, prepare two independent laboratory sample aliquots ( A and B) of the 
feed to be examined. Spike one of them (A), before extraction with a quantity of 
olaquindox, similar to that already present in the sample. Both samples are analysed. 
Calculate the analyte content in sample A and B and calculate the recovery by 
subtraction. 
5.2. Extraction 
Weigh to the nearest 0.01 g, approximately 25 g of the sample. Transfer to a 250 ml 
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cnical flask add 10 ml o« methanol (3.1) and place the flask for 5 min in the uitra-
f " u9h a folded « e , - a Slass fibre «1,,er «*K « * — 0 «P- - a * 7 .1 , „ 
* i g h , y recommended to «Iter «he dear samp,es b, using a membrane frlter ,4.3, 
additionally. Proceed to the HPLC determination (5.3). 
5 3 HPLC determination 
6
-
3 1
 ' ; T f o , ^ 9 confions are offered for guidance, other condens may be used 
provided that they give equivalent results. 
Analytical column (4.4.1 ) 
Mobit Phase ,3.4): « te r (3.3) - methano, (3.1.) mfcture, 900 . 100 <V+ V) 
Flow rate: 1.5-2ml/min 
Detection wavelength: 380 nm 
i r l n solution <3,.3, containing 2.5 u„m,, until constant peak he„hts and 
retention times are achieved. 
5.3.2. Calibration graph determine the mean peak 
Z Z ja re Ï Ï l e calibration solutton. as the o rd ina l and the co^spondrng 
concentrations In pglml as the abscissae. 
5
'
3 3
- ^ e t T p t o extract (5.2) and determine the peak heigh, (area, ofthe olacuindox 
peaks. 
6
' T Z Z ^ T ^ olaauindo, peaks o, the sample solution determine th . 
T h Ü U d o x content • (mg/kg) - «he sample is given by the followin, formular: 
c*50 
w = 
m 
Seite 3 von 4 
in which: 
c = olaquindox concentration of the sample extract (5.2) in pg/ml 
m = mass of the test portion in g 
7 Remarks 
7.1 Instead of filtration a centrifugation step could be carried out. 
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Annex 2 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
Date of analysis: [ 
Je-mail: 
fax: 
telephone: 
L OLAQUINDOX 
Unit 
Sample code 
315707 
315709 
315710 
315794 
315801 
315811 
Result 1 
(mg/kg) 
Result 2 
(mg/kg) 
I 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 3 • Instructions for handling of the samples 
1. Storage 
Store the samples at room temperature until analysis. Protect the material from direct light. 
2. Milling 
Grind the feed samples with a mill equipped with a 1 mm screen 
3. Mixing of the test samples before weighing 
Mix the entire sample thoroughly 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
Laboratory: 
Contact person: 
Date(s) of analysis: 
Phrnmatnpraphir conditions: 
• Column: 
• D As described in the method 
• D Other: 
• Mobile phase: 
• D As described in the method 
• • Other: 
• flovwate: m|/min 
• Injection volume: pi 
• Retention time of olaquindox: min 
Chromatograms: Please include representative chromatnerams
 0ft 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate die olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: % 
• Single /duplicate determinations: D single 0 duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: mg/kg 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Remarks /Comments (if necessary, continue on another nape) : 
Please complete this questionnaire and return it together with representative chromatograms to: 
Ing. U.M. Driessen 
RIKILT 
P.O. Box 230 
6700 AE Wageningen 
The Netherlands 
Fax+31-317-417717 
Thank you for your cooperation I 
APPENDIX 2 
Composition of the feed samples 
BESTMIX - Afdruk mengopdracht 
- 0 5 / 0 9 / 0 0 - IPC DIER BARNEVELD 
2 5 0 . 0 0 B i g g e n o p f o k k o r r e l HUcctf 
b i g g e n v o e r van 12 t o t 2 5 / 3 0 kg 
lo *>jr>v üultloX 4 2 lm*/ oLqujhloX 
hjA. 
Grondstof 
Weegschaal DW 1 
113 Zonbl.schr.290re 
460 Tapioca65%zetmeel 
77 Soja 45/46(arg/braz) 
Silo % Gewicht Tol. Cumul Gew. 
kg +/-Afw. kg 
( 2) 2.00 
( 4) 7.50 
( 9) 13.00 
Weegschaal DW 2 
145 Tarwe 
14 Gerst 
40 Mais 
Bijstort SP4 
34 Lynzaad 
105 Vismeel 
(voer ) 
65.9% r e 
( 9) 1 0 . 0 0 
( 11) 3 7 . 1 0 
( 12) 1 2 . 0 0 
( 0) 5 . 0 0 
( 0) 4 . 4 0 
10 
37 
65 
50. 
185. 
60. 
.00 
.50 
.00 
00 
50 
00 
Bijstort SP6 
476 Powerfood Twil melkv ( 0) 4.00 
25.00 
22.00 
Bijstort SP7 
21 Fumaarzuur 
78 L-lysine HCl 
79 DL-Methio-nine 
117 Krijt/kalksteen 
228 Monocal België 
485 Zout 
508 Prem biggen Rikilt 
t,0 j/ij- COAA- +. â&Ufu^doo 
Vloeistoffen 
474 Melasse riet >450s 
0) 
0) 
0) 
0) 
0) 
0) 
0) 
0.25 
0.17 
0.03 
0.45 
0.50 
0.10 
00 
',*j/Jy J 
20 
1 
0 
0 
2 
2 
0. 
5. 
ft' 
.00 
.25 
85 
15 
25 
50 
50 
00 
0.30 
1.13 
1.95 
1.50 
5.57 
1.80 
0.75 
0.66 
10.00 
47.50 
112.50 
50.00 
235.50 
295.50 
25.00 
47.00 
0.6Ö 
0.01 
0.01 
0.00 
0.02 
0.03 
0.01 
0.05 
( 3) 2.50 12.50 0.38 
Totaal 
20.00 
25 
10 
25 
50 
00 
50 
12.50 
12.50 
500.00 
Charge Charge 
.V.. 
.JX. 
'V" 
RETOURPRODUKT 
INSTELLINGEN 
T.R. :/6vÀ.$.°% 
V.Z. : grof/(g3)i . .9P. . . % 
Z.F. : .2,5". .... mm 
H.M. :CESo&/laag toeren 
kringloop : jaAQgft 
L.M. : voormengen . .Q. sec 
namengen SPP. sec 
M.D. : ..?3- l/h 
Meel temp 
Matrijs diam. 
K.P. 
Laagdikte Ko 
Zeef Ko 
Kruimelen 
Hotmen 
. # £ °c y&awc&^Jtf *c 
2,S x 55". mm 
J2.8.. Amp 
3S. 
& 
cm 
iron 
y£>,8 % 
% 
BESTMIX - Afdruk mengopdracht 
250.00 Biggen opfok korrel HJUKLM 
biggenvoer van 12 tot 25/30 kg 
2i5 tyAf ' Cû4*bx f 
0 kg 
7'* W 
- 0 5 / 0 9 / 0 0 - IPC DIER, BARNEVELDJÈ 
ollaiüwox 
Grondstof 
WeegBchaal DW 1 
113 Zonbl.Bchr.290re 
460 Tapioca65%zetmeel 
77 Soja 45/46(arg/braz) 
Silo % Gewicht Tol. Cumul Gew. 
kg +/-Afw. kg 
2) 
4) 
2.00 
7.50 
13.00 
Weegschaal DW 2 
145 Tarwe 
14 Gerst 
40 Mais 
Bijstort SP4 
34 Lynzaad 
105 Vismeel 
(voer) ( 9) 10.00 
( 11) 37.10 
( 12) 12.00 
65.9% re 
0) 5.00 
0) 4.40 
Bijstort SP6 
476 Powerfobd Twil melkv ( 0) 4.00 
Bijstort SP7 
21 Fumaarzuur 
78 L-lysine HCl 
79 DIi-Methio-nine 
117 Krijt/kalksteen 
228 Monocal België 
485 Zout 
508 Prem.biggen Rikilt 
Vloeistoffen 
474 Melasse riet >450s 
0) 
0) 
0) 
0) 
0) 
0) 
0) 
0.25 
0.17 
0.03 
0.45 
0.50 
0.10 
1.00 
10.00 
37.50 
65.00 
50.00 
185.50 
60.00 
25.00 
22.00 
20.00 
1.25 
0.85 
0.15 
2.25 
2.50 
0.50 
5.00 
0.30 
1.13 
1.S5 
1.50 
5.57 
1.80 
0.75 
0.66 
0.60 
0.01 
0.01 
0.00 
0.02 
0.03 
0.01 
0.05 
( 3) 2.50 12.50 0.38 
Totaal 
10.00 
47.50 
112.50 
50.00 
235.50 
295.50 
25.00 
47.00 
20.00 
1.25 
2.10 
2.25 
4.50 
7.00 
7.50 
12.50 
12.50 
500.00 
Charge Charge 
.5" 
.V. 
.V. 
.V. 
1/ 
j 
f 
. 1 / 
RETOURPRODUKT 
INSTELLINGEN 
T.R. : &W(.$P% 
V.Z. : grofItf ijj^ . OP.... % 
Z.F. : . */ f . . . . mm 
H.M. g^hóogyiaag toeren 
kringloop : ja(Û5Ê»> 
L.M. : voormengen . P.. sec 
namengen 3PP. 
M.D. : ..yS l/h 
sec 
Meel temp 
Matrijs diam. 
K.P. 
Laagdikte Ko 
Zeef Ko 
Kruimelen 
VovU 
SST.. *c k/tod* Jj?2 
2/Tx. .SS* mm 
US.. Amp 
.3sr cm 
APPENDIX 3 
Homogeneity of samples 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Homogeneity test collaborative study 
Additive 
Product : 
Olaquindox 
Feed sample: 2 ppm 
Date of determination : 
Sample 
341024 A 
341024 B 
341030 A 
341030 B 
341028 A 
341028 B 
341029 A 
341029 B 
341021 A 
341021 B 
341023 A 
341023 B 
341027 A 
341027 B 
341026 A 
341026 B 
341022 A 
341022 B 
341025 A 
341025 B 
September 22th, 
Content 
mg/kg 
1,6 
1.5 
1,5 
1.5 
1,5 
1,5 
1.5 
i;5 
1.5 
1,5 
1,4 
1,5 
1,5 
1,5 
1,5 
1,4 
1,4 
1,4 
1,5 
1,5 
2000 
Duplicate 
average 
mg/kg 
1,6 
1,5 
1,5 
1,5 
1,5 
1,5 
1,5 
1,5 
1,4 
1,5 
Homogeneity 
Cr«wion;Cvb.twe<>n = <i5% 
AvertQt 
SD (btftwaen samples) 
CV (bttwten samples) 
Grubb't tttt, single lower 
Grubb't tttt, single upper 
Grubb't tttt. double lower 
Grubb't tttt, double upper 
OK 
1,5 
0,04 
2,8 
2,065 
1,579 
0,3279 
0,6557 
Result Grubb's test 
no outlier 
no outlier 
no outliers 
no outliers 
Repeatability 
SD (within samples) 
CV (within samples) 
(sdr) 
(CV (%)) 
0,04 
2,6 
22-9-2000 TASK 4 HOM olaquindox piglet FEED tweePPM.XLS JD 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
L . . . . . . . . . 
Homogeneity test collaborative study 
Additive : 
Product : 
Olaquindox 
Feed sample: 7.5 ppm 
Date of determination : 
Sample 
345016 A 
345016 B 
345014 A 
345014 B 
345013 A 
345013 B 
345012 A 
345012 B 
345020 A 
345020 B 
345015 A 
345015 B 
345017 A 
345017 B 
345019 A 
345019 B 
345011 A 
345011 B 
345018 A 
345018 B 
September 22th, 
Content 
mg/kg 
4,8 
5,3 
5,0 
4,9 
5,0 
5,2 
5,0 
4,8 
5,0 
4,9 
4,8 
4,7 
4,9 
4,7 
5,0 
4,9 
4,7 
4,8 
4,9 
4,7 
2000 
Duplicate 
average 
mg/kg 
5,1 
5,0 
5,1 
4,9 
5,0 
4,8 
4,8 
5,0 
4,8 
4,8 
Homogeneity 
Criterion : CV,*,«,«, = < 15% 
Average 
SD (between samples) 
CV (between samples) 
Grubb's test, single lower 
Grubb's test, single upper 
Grubb's test, double lower 
Grubb's test, double upper 
OK 
4,9 
0,12 
2,5 
1,225 
1,633 
0,5833 
0,4236 
Result Grubb's test 
no outlier 
no outlier 
no outliers 
no outliers 
Repeatability 
SD (within samples) 
CV (within samples) 
(sdr) 
(CV (%)) 
0,15 
3,1 
22-9-2000 TASK 4 HOM OLAQUINDOX PIGLET FEED 7.5PPM.XLS JD 
APPENDIX 4 
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APPENDIX 5 
Olaquindox reference standard profile, identity and purity 
- G E N - 1 9 3 9 VEN l l i 4 0 IDl 
f ^ 
FAXi 
MOr""-'seT 
1 1 Ftb. iy33. 
Pi 02 
(>!kii)>r<"i.till 
APL 
CERTIFICATO Dl ANALISI NT 01/99 
CERTIFICATE OK ANALYSIS No.0t/99 
Nume prodntto: 
Product name: 
Codlce Prodotto/Product code: 
Lotto N/Batch no: 
Data Produzione/Mfg date : 
OLAQUJNDOXPURE 
.111363 
9R0416 
Aprllo S>8/Apr 98 
Anallsl N. / Analysis no. 
Data scadenza/Exp date < 
LC02 
Aprile 01/Apr Ol 
RLSULTATI/RESULTS: 
Metodo/Method
 : 
Ol ASP 
Ol COL 
ÜIODO 
UV016 
01PPB 
Defcrizlono/D«wr)|)(lon 
Aspetto/Appearance 
Colore/Colour 
Odore/Odour 
Titolo/Assny 
Perdita dl peso por 
cssicamento/Loss on drying 
Mono-N I-Ossido/Mono-Nl-Oxlde 
Mono-N4-OsÄldo/Mono-N4-Oxide 
Metüestere 
_ . 
'âpeciflcft/Specliïcation 
polvere crlsiallinn/ 
crystalline powder 
giallo/yellow 
inodore/odourloss 
min 9t max 101.5% 
max 0.5 % 
max 0.5 % 
max 0.25 % 
max 0.2 % 
RiMilfato/Resiilt 
Corrispondo/Corresponds 
Corrisponde/Corresponds 
Corricponde/Correspoiids 
99.46% 
0.07% 
max 0.5 % 
max 0.25 % 
max 0.2 % 
II (toprnnnominato Prodotio è ttato analizzato »econdo I metodi analilici DOX-AL ITALIA SpA ed e ttato 
approvuto por la venditn dal CONTROLLO QUALITAVThe above mentioned product has been analyzed 
according to Dox-al Julia Spa analytical methods and has been approved for salo by QUALITY CONTROL 
A lallsta/Analyat 
Ijucia Corbetta v 
DOX-AL ITALIA SPA 
Direttore Tecnlco/ 
Technical Director 
\t* Dr. G. Astegiano 
Data analisi/Date of analysis : 14/01/99 
DOX-AL ITALIA 9-P.A.: 20080 CORflEZZANA (Ml) • I • Til. 039-8980r01 - T»ltlt* 038-6065816 • «inn. Boo. 1.. 10000.000.000 
Ml 103097 - C.C.I.A.A. Mllino 827986 • Tribunale Monis Rtg- Soa. 11271 - H»g, Or«. 2218M 
P.I./VAT IT-00729770B6S . Codlfi» Plteul« 02117890152 
N«w AddrsM •-mill: do»IUa*l»R«lo«.H 
Sad» Opvratlvil ÜOX-AL 1TAUA S.B.A. - Via BIHL 20 • 20OI» BULWATr SUPERIORE (Ml) 
Til. 039-60202» 
F*« 039-623B44 
CANFAS 
71.316.24 
Verification of identity and purity of 
Olaquindox and Carbadox standard substance 
J.A. van Rhijn, A. Lommen and H.C.H. Kleijnen 
RIKILT, Wageningen, The Netherlands 
May 2001 
Introduction 
In order to ensure that the standard substances purchased in the framework of the CANFAS 
collaborative studies were fit-for-purpose, UV spectroscopy, ' H - N M R and mass spectrometry 
were used to verify their identity. Purity was determined by ' H - N M R . 
Materials 
Carbadox 
Olaquindox 
Supplier 
Lotnr 
Drying loss (%) 
Purity (%) 
Supplier 
Product ID code 
Lotnr 
Drying loss (%) 
Purity (%) 
Pfizer 
3E121-84QCS 
0.02 
99.3 
DOX-AL Italia 
311363 
980416 
<0.5 
99.5 
Experimental 
UV spectroscopy 
UV sample preparation: Canfas substances of olaquindox and carbadox each were dissolved 
in a mixture of acetonitril and methanol (50/50, v/v) and diluted with the same solvent to 
obtain for each substance a solution containing a concentration of exactly 4 |ig/ml. 
UV experiments: UV spectra in the wavelength range 220 to 500 nm were recorded using a 
Beekman DU60 UV-VIS spectrometer. The spectra were matched with the spectra of 
reference substances of Olaquindox (Bayer, purity 99.4%) and Carbadox (Sigma, lot 
030H0349, purity >99%) regarding both the absorbance maxima observed, indicative of the 
analytes identity, and the absorbance, indicative of their quantitative equivalence. 
Table 1 UV-VIS Spectral information for the reference standards carbadox and olaquindox 
and the deviations obtained for the corresponding Canfas standard substances. 
Compound 
Carbadox 
Olaquindox 
Absorbance 
maxima (nm) 
243.5 
308.0 
382.5 
230.5 
266.5 
383.5 
A(nm) 
-1.0 
0 
-1.0 
+1.0 
0 
+0.5 
Absorbance (AU) 
0.2216 
0.5924 
0.2036 
0.3251 
0.3649 
0.1856 
A(%) 
+6.0 
+2.3 
+3.5 
-2.8 
-4.5 
-4.9 
Results: Table 1 presents the spectral data of both the known standards and the deviation of 
those parameters observed for the Canfas-standard substances. The spectra of the Canfas-
substances were found to be identical to the reference standard substances within the 
tolerances set for standard comparability for absorbance maxima and absorbance1. 
'H-NMR 
'H-NMR sample preparation: Typically, an exact amount of TMSP (trimethylsilylpropionic-
2,2',3,3'-d4 acid, sodium salt; certificate present) is dissolved in DMSO-d6 (99.8%) 
corresponding to a concentration of ca. 5 mM. Part of this solution is stored for a control 
measurement and part is used to dissolve an exact amount of carbadox/olaquindox (ca. 5 
mM). 
'H-NMR experiments: 'H-NMR experiments were performed on a Bruker AMX 400 WB 
spectrometer. A 90 degree pulse was used; the total relaxation delay was set to 62.7 seconds; 
spectral width was 12195 Hz; number of scans was 64. The data were acquired in 64K data 
points. Before Fourier transformation a zero-filling to 256 K was applied. Calibration of 
spectra was achieved by setting the methyl resonance of TMSP to 0.00 ppm. A number of 
checks on the equipment were performed on a weekly basis, such as temperature calibration 
and stability checks as well as line width checks as described elsewhere. 
'H-NMR structural conformation: The resonances of the samples, which were to be 
examined, were compared to those of known commercial origin. Multiplet structures, 
integrals and resonance positions were fully compatible. Assignments of resonances were 
done on the basis of expert knowledge. Thus sample identity could be confirmed. 
'H-NMR quantification: Integrals of non-overlapping resonances of non-exchangeable 
protons were determined and calibrated with regard to the internal standard (TMSP). 
Knowing the exact amount of the sample of interest and the internal standard (100% pure) the 
concentration of the sample of interest can be calculate relative to the internal standard from 
the integrals. 
Results (see also Figure 1 to 31 
1. Both carbadox and olaquindox were confirmed with respect to identity. 
2. The carbadox content was determined in duplo giving a purity of resp. 95.5% and 94.5% 
on a w/w basis 
3. The olaquindox content was determined in duplo giving a purity of resp. 93.3% and 
96.3% on a w/w basis 
4. In both samples traces of impurities in the procent range could be detected in the 'H-NMR 
spectrum. 
Mass spectrometry 
MS sample preparation: The Canfas-substances of olaquindox and carbadox each were 
dissolved in a mixture of acetonitril and methanol (50/50, v/v). The stock solution was diluted 
to obtain for each substance a solution containing 10 .^g/ml of the analyte in a mixture of 
acetonitril / methanol / 1 mM ammonium acetate (25/25/50, v/v). The same solutions were 
made from reference standards of olaquindox and carbadox. 
MS experiments: The mass spectrometer was calibrated according to the manufacturers 
instructions prior to use. 
Using a syringe pump at a flow rate of 5 ^ l/min, the 10 ng/ml solutions were subsequently 
infused continuously, into an LCQ ion-trap mass spectrometer equipped with an ESI interface. 
The ESI interface was operated in positive ion mode at standard settings with regard to 
capillary temperature, sheath gas and auxiliary gas flows. Positive ion mass spectra were 
recorded in MS'.mode as well as in MS" mode (n ranging from 2 to 4) using the protonated 
molecule and adduct ions and fragment ions present in the MS ; spectrum as the primary 
precursor ions in the MS" experiments. Several MS" product ions were used in further MS" 
experiments (n>2) as precursors for further fragmentation. 
Results: Figure 4 gives a schematic representation of the ions formed by carbadox in the MS" 
experiment. The molecular mass of carbadox was confirmed and the same fragmentations 
were observed, using identical experimental conditions, in the Canfas-substance and the 
reference standard. 
Figure 5 gives a schematic representation of the ions formed by olaquindox in the MS" 
experiment. The molecular mass of olaquindox was confirmed and the same fragmentations 
were observed using identical experimental conditions, in the Canfas-substance and the 
reference standard. 
Conclusions 
Carbadox 
The identity of the Canfas standard substance Carbadox could be confirmed by UV, ' H-NMR 
as well as mass spectrometry. 
Its purity was determined in duplicate by 'H-NMR to be on average 95.0 %. This is slightly 
lower than the purity declared by the manufacturer (99.3%). Trace level (percentage range) 
amounts of unknown impurities were present in the NMR spectra. By UV spectroscopy the 
purity of the Canfas standard substance was shown to be of similar purity as the reference 
standard to within 5% which is in agreement with the results from 'H-NMR. 
Olaquindox 
The identity of the Canfas standard substance Olaquindox could be confirmed by UV, *H-
NMR as well as mass spectrometry. 
Its purity was determined in duplicate by 'H-NMR to be on average 94.8%. This is slightly 
lower than the purity declared by the manufacturer (99.5%). Trace level (percentage range) 
amounts of unknown impurities were present in the NMR spectra. By UV spectroscopy the 
purity of the Canfas standard substance was shown to be of similar purity as the reference 
standard to within 5% which is in agreement with the results from 'H-NMR. 
References 
1) RIKILT standard operating procedure A0628, Veterinary drugs - preparation and quality 
control of standard substances. 
2) Lommen, J.M. Weseman, G.O.Smith and H.P.J.M. Notebom (1998), Special issue "NMR 
in Environmental Sciences". Biodegradation, 9, 513-525. 
3) H.RJ.M. Notebom, J.M. Weseman, R. van de Jagt and A. Lommen (2000), Special issue 
"NMR in Biotechnology", Journal of Biotechnology, 77,103-114. 
I 
- O 
u 
9 
M O 
M O Ol 
S M Q 
m 
fl> 
•ri 
•P 
•H 
M 
3 g* 
•H 
II 
55 I O 
CO 
tu 
O 
- CM 
CO 
SB 
- UI 
u 
w 
CU 
co 
g 
§ 
u 
vo 
- 00 
cc 
CD 
en 
I 
ft 
- o 
•H 
+j 
U -rt 
<u u 
M O 3 
M O M g. 
î ï î il 
S K O H (3 
H.« 
- CM 
CO 
CM 
LU 
O - S S 5 - 0 
- *» 
- m 
- u> 
- r-
- oo 
- CA 
CO 
LU 
CC 
- H 
- CM 
- en 
- «» 
- m 
vr> 
- r-
- œ 
- en 
Carbadox 
MS1 [M+H]+ 
m/z=263 
[M+NH4]+ 
m/z=280 
MS2 m/z 
231 - 203 -163 -135 -129 
m/z 
263 
MS3 m/z 
203-175-131-130-104-77 
v 
m/z 
235-231-135-129-101 
MS4 m/z 
175 -130 
Figure 4 Schematic representation of the fragmentations observed for Carbadox in 
an MS" experiment. 
Olaquindox 
MS1 [M+H]+ 
m/z=264 m/z=177 
MS2 m/z 
246-221-204-191-177 
nï/z m/i 
m/z 
160-135 
MS3 
l/Z 
177 
m/z 
229 - 202 - 177 
z 
160-135 
MS4 m/z 
185-177-159-131-104 
Figure 5 Schematic representation of the fragmentations observed for Olaquindox 
in an MS" experiment. 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 12 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
125748 
125760 
125785 
125795 
125818 
125820 
Result 1 
(mg/kg) 
N.S.D. 
1,97 
1,54 
4,84 
N.S.D. 
5,84 
Result 2 
(mg/kg) 
N.S.D. 
2,01 
1,51 
4,78 
N.S.D. 
5,85 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQU1NDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: 22 Novlembre 2000 
Chromatographie conditions: 
• Column: 
• g] As described in the method. 
• Q Other 
Mobile phase: 
• ^ As described in the method. 
• • Other: 
• Flow-rate: 1,2ml/mln 
• injection volume: SO pi 
• Retention time of olaquindox: « 9 min. 
Chromatoorams: Please include repräsentativ« chrgmatoorams «ft 
• Blind positive feed samples 
• Blind blank feed sample 
Please Indicate the olaquindox peak with an arrow 
Recovery results; 
• Percentage recovery: 78% 
• Single / duplicate determinations: ^  single Q duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: 3 mg/kg 
Injection Date 
Sample Name 
Acq. Operator 
P V 1 1 / 0 0 1 3 : 1 0 : 3 6 
Acq. Method 
Laat changed 
A n a l y s i s Method 
L a s t changed 
C:\HPCHEM\1\}' 
. 22 /11 /0« 13*3-8:59 
Cl\HrcnEM\.lV 
2 2 / 1 1 / 0 0 19t 'bl t44 
(modi f.i.ed a l t e r l o a d i n g ; 
- C&NFAS/Olaquindoag 
DAD1 A, fels<S80,4 Ref«SB«ä)fl| 
\0LAQC0L.M 
bY 
f\OLAQCQL.M 
by 
V i a l i 1 
I n j Volume : 50 vl 
nv\u 
25 
20H 
is H 
10 4 
- , r I • | i r-
1D mir 
OL*** i a ^ 8 & 
Area Percent Report 
Sorted By 
^.ltiplier 
imlution 
Signal 
l.onno 
1.0000 
Signal l: DAD1 A, Slg-380,4 Re£-500f20-.-
Rcoulta obtained with enhanced integrator! 
Peak RetTime Type Width Area Height 
# [min] [min] [mAu*s] [mAu] 
Area 
% 
1 9.250 BB 
Total« : 
0.3105 43.85185 
43.85185 
I' 1 I 
1-7R619 100 .0000 
1 .75619 
*++ End o f Report *** 
ir'rument 1 2 2 / 1 1 / 0 0 1 9 : 5 1 : 4 8 Page 1 o f 1 
Tnjfiction. Dat« 
Sample Name 
Acq. Operator 
: 2 2 / 1 1 / 0 0 1 4 t 0 1 : 2 8 
/ . 
: Cl\HPCHEM\^ AOLAQCQL.M 
: 2 2 / l l / U U 1 3 : 0 8 : 5 9 b\ 
i C:\HPCHEM\r _~ VOLAUUUIiJu 
{ 22/11/DO 1 9 : 6 1 : 4 4 by 
(modif ied a f t e r l o a d i n g ; 
CANFAS/Olaqulnrio*. 
M M A, SiO-330 4 Wrf*S0ft» (( 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
Vial j 1 
Inj Volume : 50 ul 
" 0 3 > 
otAsa IJLSTE, 
Area Percent Report 
Sorted By 
Ultlpli« 
•lution t er J 
Oignal 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig-380,4 Ref-500f20 
Results obtained with enhanced integrator! 
Peak RetTimo Type Width 
# Cmin] [min] 
1 , , 1 
1 9 . 1 8 1 BV 0.3120 139.7R018 
Area 
[mAu*o] 
Height 
[mAu] 
Area 
% 
I 
Totale 139.76018 
5.39218 100.0000 
5.39218 
*** End or Report *** 
^ent 1 22/11/00 19:53:52 Page 1 of 1 
[ Inject ion Dato : 22 /11 /00 1 4 I 2 7 I 0 6 
S*mpla Nam« 
Acq. Operator j . j . 
Acq. Method 
Last changed 
: C:\HPCHEM\1\ \0LAQC0L.M 
; 22/11/0Ü 13.'l>b:59 try. 
Analysis Method : C:\HPCHEM\1V" ^OLAQCOL.M 
Last changed : 22/11/00 19:'Sl:44l by 
(modified after, loading) 
„ CA VITAS/Ol a qu 1 nriox 
ÜADTK «8=380,4 Rar-SQO^ D C 
Vial : 1 
Inj Volume : 50 p± 
Sorted. By 
Q U t i p l i e r 
Di lut ion 
No peaks found 
0LÛQ. laetflvfl 
Area Percent Report 
Signal 
1.0000 
1.0000 
*** End or Report A*' 
.strument 1 22/11/00 19:55:18 Page 1 of 1 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 15 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
155711 
155735 
155741 
155761 
155776 
155784 
Result 1 
(mg/kg) 
blank 
1,25 
1,12 
blank 
4,60 
4,14 
Result 2 
(mg/kg) 
blank 
1,02 
1,34 
blank 
3,52 
4,76 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 • OLAQUINDOX 
Anmx 4 • Questionnaire 
Data(s) of analysis: . . . J & & v t â V t f . t t / * * ^ „ 1 . 3 £ £ ^ . 
Chromatographic pnnriitions: 
• Column; 
• û As described in the method 
• Xou,er: •"bX>fà£àùk..jQ!k&...Sl/Hlirii !^.XÂ\$,^...+!&,*Q..<£ï?,***' 
• Mobile phase: 
• )£fe described in the method 
• 0 Other: 
• Fkwfate: „.xi.tà m|/Wn 
• Injection volume: ..££?,...ul 
• Retention time of olaquindox: . . £ : i min 
Chromatneramg! Please Include representative chramatniyramj ffft 
• Blind positive feed samples 
• Blind blank feed sample 
Please inécatc the olaquindox peak vritti an arrow 
• Percentage recovery: ?.?.. % 
• Single /duplicate determinations;^single 0 duplicate 
• If duplicate, please give both percentages: % and 96 
• Spiking level: ..3?.Q... mg/kg 
' a t a F i l e C: \JHFL'HÜM\l\DA ,rA\ADL\Oiaq0315 .D Sample Name: 1! 
Injection Date 
Sample Name 
Acq. Operator 
Sequence File 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
11/3/00 4:22:22 
155711 
adl 
PM Seq. Line 
Vial 
inj 
Inj Volume 
6 
6 
1 
20 pi 
C:\HPCHEM\l\SEQUENCE\MOLAQVAL.S 
C:\HPCHEM\1\METH0DS\M0LAQVAL.M 
11/3/00 2:34:40 PM by adl 
C:\HPCHEM\1\METH0DS\M0LAQVAL.M 
11/6/00 2:27:24 PM by 
DAD1 A, Sig=380,4 Ref=450,50 (ADUOLAQ0315.D) 
mAUl | R 
External Standard Report 
éorted By hlib. Data Modified 
Multiplier 
Dilution 
Signal 
Monday, November 06, 2000 2:14:45 PM 
1.0000 
1.0000 
Signal 1: DADl A, Sig=380,4 Ref=450,50 
RetTime Type Area Amt/Area Amount Grp Name 
[min] [mAU*s] [ng/ul] 
I I 
5.110 
Totals : 0.00000 
Results obtained with enhanced integrator! 
1 Warnings or Errors : 
Warning : Calibrated compound(s) not found 
olaquindox 
trument 1 11/6/00 2:27:33 Page 1 of 1 
Ita'File C:\HPCHEM\l\DATA\ADL\olaq0320.D sample warne: ±oof*± 
Injection Date 
Sample Name 
Acq. Operator 
: 11/3/00 6:08:37 PM 
: 155741 
: adl 
Seq. Line 
Vial 
inj 
Inj Volume 
11 
11 
1 
20 /il 
© 
Sequence File 
Acq. Method 
Last changed 
Analysis Method 
Last chanaed 
C:\HPCHEM\1\SEQUENCE\M0LAQVAL.S 
C:\HPCHEM\1\METH0DS\M0LAQVAL .M 
11/3/00 2:34:40 PM by adl 
C:\HPCHEM\1\METH0DS\M0LAQVAL.M 
11/6/00 2:27:24 PM by 
External Standard Report 
Äorted By 
alib. Data Modified 
Multiplier 
Dilution 
Signal 
Monday, November 06, 2000 2:14:45 PM 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=380,4 Ref=450,50 
RetTime Type Area Amt/Area Amount Grp Name 
[min] [mAU*s] [ng/ul] _
 § 
I 20.12256 3.3420le-2 6.72497e-l olaquindox 
6.72497e-l * £ -il.S^ -^i/fc 
5.107 PB 
Totals : 
Results obtained with enhanced integrator! 
*** End of Report *** 
strument 1 11/6/00 2:28:09 PM Page 1 of 1 
ata File C:\HPCHEM\l\DATA\ADL\olaq0324.D Sample Name : 1 
Injection Date 
Sample Name 
Acq. Operator 
Sequence Pile 
Acq. Method 
Last changed 
Analysis Method 
Last rhanoed 
11/3/00 7:33:32 
155776 
adl 
PM Seq. Line 
Vial 
Inj 
Inj Volume 
15 
15 
. 1 
20 pi 
C:\HPCHEM\l\SEQUENCE\MOLAQVAL.S 
C:\HPCHEM\l\METHODS\MOLAQVAL .M 
11/3/00 2:34:40 PM by adl 
C:\HPCHEM\1\METHODS\MOLAQVAL.M 
11/6/00 2:27:24 PM by 
External Standard Report 
p o r t e d By 
Pfcalib. Data Modified 
Multiplier 
Dilution 
Signal 
Monday, November 06, 2000 2:14:45 PM 
1.0000 
1.0000 
Signal 1: DADl A, Sig=380,4 Ref=450,50 
RetTime Type Area Amt/Area Amount Grp Name 
[min] _ [mAU*s] [ng/ul] 
5.091 BB 
Totals : 
55.72574 3.16900e-2 1.76595 olaquindox 
1.76595 * £ -
 V s - £ CU^/Kj 
Results obtained with enhanced integrator! 
End of Report *** 
Strument 1 11/6/00 2:28:39 PM Page 1 of 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
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Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Analyte: OLAQUINDOX 
Unit 
Sample code 
165708 
165719 
165751 
165774 
165802 
165816 
Result 1 
(mg/kg) 
5,66 
1,56 
not found 
1,66 
not found 
5,65 
Result 2 
(mg/kg) 
4,98 
1,7 
not found 
1,65 
not found 
5,54 
CAIMFAS COLLABORATIVE STUDIES OCTOBER 2000 - QLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: 2000-10-23, 2000-11-14,2000-11-15 (each assay one day) 
Chromatographie conditions: 
• Column: 
• o As described in the method 
• x Other Spherisorb ODS 2,10 urn, 250 x 4.6 mm 
• Mobile phase: 
• x As described in the method 
• D Other 
• Flow-rate: 1.7 ml/min 
• Injection volume: 20 ul 
• Retention time of olaquindox: 9.5 min 
Chromatoarams: Please include representative chromatoarams of-
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: 76.5 % 
V Single / duplicate determinations: D single x duplicate 
• If duplicate, please give both percentages: 76.9 and 76.0% 
• Spiking level: 3.0 mg/kg 
Öpactvjii^dbx 
CH . 1 C .S 5.00 ATT 2 OFFS 10 11/15/00 14:06 
S .P 
Qßaqu^cAcK 
M* 
" 1 •37' 
INJ NO. OF STD : 1 / 1 REP » 1 s t l e v e l 
D - 2 5 0 0 
METHOD: TAG: 4 9 5 CH: 1 
F I L E : 3 CALC-METHOD: E X T - S T D T A B L E : 9 CONC: HEIGHT 
1 1 / 1 5 / 0 0 1 4 : 0 6 
NO. RT 
4 9 .40 
AREA HEIGHT UG/ML NAME 
4351 172 OLA 
S .P 400 
10 .71 
5 .86 
D-2500 ^ 
METHOD: TAG: 496 CH: 1 
FILE: 3 CALC-METHOD: EXT-STD TABLE: 9 CONC: HEIGHT 
11/15/00 14:19 
Oj?ÛOUi/Kclo,K 
CH . 1 C .S 5 . 0 0 ATT 2 OFFS 10 1 1 / 1 5 / 0 0 12 :14 . S t a x W k AiOM» jj jWJl 
,18 
S .P 9 .61 
XSXHlC 
t ,90 
I N J NO. OF STD : 1 / 1 REP » 1s t l e v e l 
"P-2500 
METHOD: TAG: 489 CH: 1 
FILE: 3 CflLC-METHOD: EXT-STD TABLE: 9 CONC: HEIGHT 
11/15/00 12:14 
NO . RT 
5 9 .61 
AREA HEIGHT UG/ML NAME 
10173 386 OLA 
Samfä cede 
CH . 1 C S 5 . 0 0 ATT 2 OFFS 10 1 1 / 1 5 / 0 0 1 2 : 2 7 / f t f»M3 
S.P 400 
OQoLCjKJwickx 
^yaqdUsnacK 
CH . 1 C .S 5 . 0 0 RTT 2 OFFS 10 1 1 / 1 5 / 0 0 1 0 : 2 3 
s .p we— 
ste/*M 3,5to/^M 
9.38 6- QoxeiUvKe/oK 
INJ NO. OF STD : 1 / 1 REP > 1st level 
D-2500 
METHOD: TAG: 483 CH: 1 
FILE: 3 CflLC-METHOD: EXT-STD TABLE: 9 CONC: HEIGHT 
NO. RT AREA HEIGHT U6/ML NAME 
4 9.38 27974 1025 2.540 OLA 
11/15/00 10:23 
CH . 1 C .S 5.00 ATT 2 OFFS 10 11/15/00 10:36 S'an,p& ccfk. 
S .P 4 0 0 Qfiaai-Wo/cA 
D - 2 5 0 0 1 1 / 1 5 / 0 0 1 0 : 3 6 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 17 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
175703 
175718 
175730 
175775 
175817 
175828 
Result 1 
(mg/kg) 
0 
5,60 
2,07 
0 
1,99 
5,58 
Result 2 
(mg/kg) 
0 
5,66 
1,99 
0 
1,92 
5,63 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
n t , , , , . 41. 10< Zooo Date(s) of analysis: 
Chromatographic conditions: 
• Column: 
• a As described in the method ^ 
. o Other: .MZl**r.k ?..?.?. <?.?.?.;.? <Ofc„ 
• Mobile phase: 
• yi As' described in the method 
• a Other: 
• Flovwate:....:/.?. ml/min 
• Injection volume: .-^.T?....pi 
"7 0 
• Retention time of olaquindox: .'../.fr. mm 
Chromatograms- Please include representative chromatoerams of: 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery:....'/. % 
• Single / duplicate determinations: D single Jsf duplicate 
• If duplicate, please give both percentages: S M % and £*.'.?. % 
• Spiking level:..-?.«. mgAg 
D-7000 HSM: Olaquindox Series: 0199 
Sample Name: Standard 2,5pg/ml 
Analyzed: 11 .10 .00 13:39 Reported: 13.11.00 10:46 
Processed: 13.11.00 10:46 
Data Pa th : C:\Win32App\HSM\OLAQU\DATA\0199\ 
A p p l i c a t i o n : Olaquindox Ser ies :0199 
I n j e c t i o n from t h i s v i a l : 1 of 1 Via l Number: 1 
Volume: 20,0 u l 
Sample D e s c r i p t i o n : 
Chrom Type: Fixed WL Chromatogram, 380 nm 
I 3 — 
2 -
1 — 
0 —_• 
" " l " " | | " " | ' ' ' ' I ' ' ' ' | ' ' • ' I • • • • | • • • • I • • • • | ] • • • •
 t . • • • [ . . | 
1 1 2 3 4 5 6 7 8 9 
R e t e n t i o n T i n a (min) 
Acquisition Method: Olaquindox 
Column Type: RP 18 
Pump A Type: L-7100 
Solvent A: MeOH/H20 
Solvent C: MeOH/H20 
Peak Quantitation: AREA 
Calculation Method: EXT-STD 
Name RT 
Olaqu 
4,19 
4,71 
5,66 
7,02 
7,87 
Area 
558 
141 
124 
39485 
0 
40308 
Developed by: 
Solvent B: MeOH/H20 
Solvent D: MeOH/H20 
Sample Amount: 1,000 
Scale Factor 1: 1,000 
Cone 1 
o, 
o, 
o, 
2, 
o, 
000 
000 
000 
607 
000 
2,607 
BC 
BB 
BB 
BB 
MC 
Page Indicator 1 / 2 
D-7000 HSM: Olaquindox 
Sample Name: 175775 
Analyzed: 11.10.00 17:40 
Data Path: C:\Win32App\HSM\OLAQU\DATA\0200\ 
Application: Olaquindox 
Injection from this vial: 1 of 1 
Series: 0200 
Sample Description: 
Reported: 13.11.00 10:35 
Processed: 13.11.00 10:34 
Series:0200 
Vial Number: 9 
Volume: 20,0 ul 
Chrom Type: Fixed WL Chromatogram, 380 nm 
I 
X? 
m 
c 
e 
' l " " I " 1 ' l ' ' " | " " l " " | " " i " " | " " i " " I ' I I ' I I I | ( M 
4 5 6 
Rétention Tin» (min) 
' I 
7 
Acquisition Method: Olaquindox 
Column Type: RP 18 
Pump A Type: L-7100 
Solvent A: MeOH/H20 
Solvent C: MeOH/H20 
Peak Quantitation: AREA 
Calculation Method: EXT-STD 
Name RT Area 
Developed by: 
Solvent B: Me0H/H20 
Solvent D: MeOH/H20 
Sample Amount: 0,500 
Scale Factor 1: 1,000 
Cone 1 
7,65 6506 0,000 
6506 0,000 
Peak rejection level: 0 
BC 
BB 
Page Indicator 1 / 1 
D-7000 HSM: Olaquindox Series: 0199 
Sample Name: 175828 
Analyzed: 11 .10 .00 15:39 
Data Path: C:\Win32App\HSM\OLAQU\DATA\0199\ 
A p p l i c a t i o n : Olaquindox 
I n j e c t i o n from t h i s v i a l : 1 of 1 
Sample Desc r ip t i on : 
Reported: 13.11.00 10:25 
Processed: 13.11.00 10:25 
Ser ies :0199 
Vial Number: 13 
Volume: 20,0 ul 
% 
X? 
Chrom Type: Fixed WL Chromatogram, 380 run 
Retention Tims (min) 
Acquisition Method: Olaquindox 
Column Type: RP 18 
Pump A Type: L-7100 
Solvent A: MeOH/H20 
Solvent C: MeOH/H20 
Peak Quantitation: AREA 
Calculation Method: EXT-STD 
Name RT 
Olaqu 6,99 
8,42 
Area 
42790 
253 
43043 
Developed by: 
Solvent B: MeOH/H20 
Solvent D: MeOH/H20 
Sample Amount: 0,500 
Scale Factor 1: 1,000 
Cone 1 
5,634 
0,000 
5,634 
Peak rejection level: 0 
Page Indicator 1 / 1 
BC 
MC 
BB 
D-7000 HSM: Olaquindox Series: 0200 
Sample Name: 175817 
Analyzed: 11.10.00 17:50 Reported: 13.11.00 10:37 
Processed: 13.11.00 10:37 
Data Pa th : C:\Win32App\HSM\OLAQU\DATA\0200\ 
A p p l i c a t i o n : Olaquindox Ser ies :0200 
I n j e c t i o n from t h i s v i a l : 1 of 1 Vial Number: 10 
Volume: 20,0 ul 
Sample Desc r ip t ion : 
Chrom Type: Fixed WL Chromatogram, 380 nm 
I 
J« 
Retention Tin» (min) 
Acquisition Method: Olaquindox 
Column Type: RP 18 
Pump A Type: L-7100 
Solvent A: MeOH/H20 
Solvent C: MeOH/H20 
Peak Quantitation: AREA 
Calculation Method: EXT-STD 
Name RT Area 
Developed by: I 
Solvent B: MeOH/H20 
Solvent D: MeOH/H20 
Sample Amount: 0,500 
Scale Factor 1: 1,000 
Cone 1 
Olaqu 
3 , 8 3 
4 , 3 3 
5 ,12 
7 , 2 8 
2176 
663 
0 
14085 
16924 
0,000 
0,000 
0,000 
1,990 
1,990 
BC 
BB 
BB 
MC 
Page Indicator 1 / 2 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 18 
Annex 2 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Task 4 COLLABORATIVE STUDY 
Analyte: 
e-mail: 
fax: 
telephone: 
| OLAQUINDOX | 
Unit 
Sample code 
185693 
185695 
185731 
185733 
185758 
185823 
Result 1 
(mg/kg) 
5,78 
6,18 
1,56 
1,67 
Not Detected ; 
LOD<0,5 
Not Detected ; 
LOD<0,5 
Result 2 
(mg/kg) 
5,92 
6,12 
1,52 
1,65 
Not Detected ; 
LOD<0,5 
Not Detected ; 
LOD<0,5 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 • Questionnaire 
Date(s) of analysis: ...2ÜU ^£pU..(?.Q.....^...£îW.0O.. 
Chromatographic conditions: 
• Column: 
• D As described in the method 
. )(0ther: * ^ . J T . . A / i î j « u i y V . . i ^ ^ ^ 
• Mobile phase: 
• XAs described in the method 
• a Other: 
• Flovwate: ..rfi-.f-.O.... ml/min 
• Injection volume: .AÖ.TSQJI 
• Retention time of olaquindox: &fk. min 
Chromatograms: Please include representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: ^ 3,5 % 
• Single / duplicate determinations: G single j ( duplicate 
• If duplicate, please give both percentages: -Wyi % and 3/jJ, % 
• Spiking level: ...3 mg/kg 
' f i n t of window J Ö : c u r r e n t K,iu.-omat.u<ji.€uinoi 
C u r r e n t Chromatogram(s) 
DAD1 A, Sig=380,4Ref=500,100 -1\OLA001 ~2\OLAQ0006.D) 
mAU 
30 
25-
20 -
15 
10-
J\ 
Sample feed 185733 (#1.5 mg/kg) 
4 
\Area: 77.785 
10 frill 
01/12/00 12:37:44 mcr Page 1 of * 
^lnt or winauw oy. xcu-yei. T uj.u±.aj-x oF«=^ 
Target + Library Spectrum 
DAD1,8.237 (5.7 mAU, - ) Kef=aCÖ7 & 8.507 of OLAQ0006.D 
mAU 
H 
<H 
Sample feed 185733 ( |f1.5 mg/kg) 
Olaquindox Standard 1 Mg/ml 
Spactra Overlay ( match f 99.8%) 
300 
- , — . — , — r -
320 340 360 380 
' 01 /12/00 12:42:18 mcr Page 1 of 1 
Pr in t of window 38: Current cnromatogranus; 
C u r r e n t Chromatogram (s ) 
1
 DAD1 A, Sig=380,4 Ref=500,1 CD. 
DAD1 A, Sig=380,4Ref=500,100' 
mAU 
50 
40 
30-
20-
10 
~1 ' r" 
2 
—| r-
4 6 
1 \OLA001-HOLAQCO06. D) 
•1\OLA001~1\OLAQCO02.D) 
Blank feed Cock. &5 15& 
Olaquindox standard 1 pg/ml 
Olaquindox peak 
I 
^ Are«: 383823 
1 1 1 , r-
10 
- 1 — I — I -
12 14 mit 
01/12/00 12:33:59 mcr Page 1 of 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 20 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
205713 
205729 
205739 
205796 
205809 
205822 
Result 1 
(mg/kg) 
neg 
1.72 
1,52 
4,85 
neg 
4,65 
Result 2 
(mg/kg) 
neg 
1,6 
1,59 
4,78 
ne9 
4,78 
JSJ 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annax 4 - Questionnaire 
Date(s) of analysis- ..A$J.M}J.9£?.. 
Chromatographic conditions: 
• Column: 
• tfAs described in the method flôèY'rmû fWcc/U C\$. JSO x ^W/w/w S Ann 
• • Oilier: 
• Mobile phase: 
• ï f As described in the method 
• D Other: 
• Flmwate: ..:4.i& ni/ivin 
• Injection volume: ..5&....U1 
Retention time of olaquindox: {?*&. min • 
Chrnmatapram«; Mease Include representative chromatOErami oft 
• Blind positive feed samples 
• Blind blank feed sample 
« t e e imScete the olaqw'ndaxpeak with an arrow 
HecQverv résulte; 
• Percentage recovery: i.wrrÄ 
• Single / duplicate determinations: D singlo fr duplicate 
• If duplicate, please give both percentages: $?$% and JRÇëfft 
• Spiking level: .«k?!?.. mg/kg 
Data File D:\ANAL .7\RrKILT\RIKNOV03 .D Sample Name: 205796 
Injection nal-R 
Sample Name 
Acq. Operator 
Acq. MeLhud 
Lost changed 
Analysis Method 
Last changed 
11/28/2000 1:26:31 PM 
205796 a 
ea 
C: \HPCHBM\l\METHODS\QLAQ-iUC.M 
11/28/2000 1.-25:55 PM by ea 
(modified alter loading) 
C:\HPCHEM\1\METH0DS\0LAQ-RK.M 
11/28/2000 3:11:17 PM by ea 
(modified after loading) 
Seq. Line 
Vial 
in;} 
Inj Volume 
3 
22 
1 
50 /*1 
Col Alltima 250 mm 3-4-Sfi 
UALM A, üia*JaU^U Wil^430,100 (KIKILI\KIKNOV03.U) 
> : S M * U M I 
ßoart od By 
Ca"! 1b. nat-.a Modified 
Multiplier 
Dilution 
External Standard Report 
Signa} 
Tuesday, November 28,
 2 0 0 0 3:10,06 PM 
1.0000 
Siyiittl 1; BAD1 A, Gig-300,20 Rof-450,100 
ifttTin 
[min] Re me Type Area Amt/Area Amr,,,«* 
...ui^ üL.u. , Ä ] Grp Nam* I 6.4X4 MM 
Totals s 
178.33818 1.47681C-2 2.63371 
2.63371 
Results obtained with enhanced in teara tow 
End of Report ***" 
4. s A z ^ / ^ 
O1
»quindox 
HP 1090 11/28/2000 3:15:03 PM ea 
Pay« 1 of 1 
Data Pile ü:\ANÄl#' j/\RIKILT\RIKNOV05 .D Sample Nam«: 205713 ' ^ 
Injection Date 
Sample Name 
Acq. Operator 
Acq. Method 
Laat changed 
Analysis Method 
Last changed 
11/28/2000 1:51:46 
205713 a 
ea 
PM 
C:\HPCHBM\1\METH0DS\0LAQ-RK.M 
11/38/2000 1:Sir09 PM by ea 
(modified after loading) 
C:\HPCHEM\1\METH0DS\0LAQ-RK.M 
11/28/2000 3:11:17 PM by ea 
(modified after loading) 
Seg. Line : 
Vial : 
inj i 
Inj Volume : 
: 5 
24 
1 
: 50 fil 
Col Alltima 250 mm 3-4-9A 
DAD1 A, Blfl=3aU.^U H6Tg45U.10tq>miCnwKlTOVDSJPr 
s 
1 
mid 
External Standard Report 
°orted By 
Calib. n*t» Modified 
Multiplier 
DUution 
Signal 
Tuesday, November 28, 2000 3:10:06 PM 
1.0000 
1.0000 
S J
-yual i s DAD1 A, O i g - 3 8 0 , 2 0 Re f -450 , 
RetTime Type 
Iniin] 
6.618 
Total« 
Area 
[mAU*s] 
Amt/Area 
100 
Amount 
[ug/ml] 
Grp Name 
Olaquindc* 
0.00000 
Results obtained with enhanced integrator! 
1
 Warnings or Errors : 
Warning
 : Calibrated compound(R) not found 
y ^ 
IP 1090 11/28/2000 3:13:bU VM ea Pago 1 of a 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 21 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2: 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Date of analysis: 
Analyte: [ OLAQUINDOX 
Unit 
Sample code 
215715 
215770 
215791 
215797 
215813 
215827 
Result 1 
(mg/kg) 
2,0 
0,0 N.D. 
0,0 N.D. 
5,4 
2,0 
5,3 
Result 2 
(mg/kg) 
2,0 
0,0N.D. 
0,0 N.D. 
5,3 
2,0 
5,2 
2\ 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
Datels) of analysis: «]>.\AQ\.M£?. 
Chromatographic rnnrtitinns: 
• Column: 
• D As described in the method _ 
. ,&<pther: ^^.Ç^^\h..S.Ç.:S. .^.^..xk,£.^.^...(?L/u+ ) 
. Mobilephase: + SuPeuÖ»«.fc L<L-Ag / 
• G As described in the method 
• > ( X h e r : ^ M ^ . . ^ ^ 
• Flow-rate: .......i.lrt... ml/min 
• Injection volume: ..<£.vr:...ul 
• Retention time of olaquindox: ."*;.£ min 
Chromatnerams: Please jnHiirie representative chromatOErams of: 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Recovery results; 
• Percentage recovery:Q...,r. % 
• Single / duplicate determinations: o single ^duplicate 
• If duplicate, please give both percentages: .<£?. % and .R.U. % 
• Spiking level:...9A.Q. mgAg 
\ CT\HPCHEM\1\CROMAT\OLACÄNF1\791-B.D Sample Name: 79: 
© 
etion Date 
Name 
Operator 
23/10/2000 21.30.34 
791-B 
Different Inj Volume from Sequence 
Acq. Method 
Last changed 
Analysis Method 
Last changed 
C:\HPCHEM\1\IZ 
28/08/2000 16.09.10 bv 
C:\HPCHEM\1\ 
04/12/2000 15.32.39 
(modified after loading) 
Seq. Line 
Vial 
Inj 
Inj Volume 
Actual inj Volume 
16 
13 
1 
10 pi 
20 pi 
External Standard Report 
ported By 
Calib. Data Modified 
Multiplier 
Dilution 
Signal 
04/12/2000 15.32.39 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig=365,8 Ref=off 
RetTime Type 
[min] 
Area Amt/Area Amount Grp 
[mAU*s] [ng inj.] Name 
7.658 
Totals : 
OLAQ-olaquindox 
0.00000 
Results obtained with enhanced integrator! 
1 Warnings or Errors : 
Warning : Calibrated compound(s) not found 
rv - Visibile 04/12/2000 15.32.42 
Page 1 of ^  
C : \HPCHEM\1 ^ 0MAT\0IACANF1\797-A. D 
L____„_=„____L_=M==««=== - = . . . . . . . . . . . . . . . . . . (3? 
x Sample Name: 797-A 
ection Date 
eunple Name 
cq. Operator 
23/10/2000 21.53.52 
: 797-À 
' Different Inj Volume from Sequence ! 
Acq. Method : C:\HPCHEM\l\ . - -
Last changed : 28/08/2000 16.09.10 by 
Analysis Method : C:\HPCHEM\1N 
Last changed : 24/10/2000 14.40.09 
(modified after loading) 
~ ~ ~DADf A, Sfc-365.8 R«f-o»f (OLACANF1V7S7«A.uj 
Seq. Line : 17 
Vial : 14 
Inj : 1 
Inj Volume : 10 /xl 
Actual Inj Volume : 20 ßl 
mAU 
60 
«H 
30 
20-) 
10 
.^ 
External Standard Report 
Signal 
24/10/2000 13.49.03 
1.0000 
1.0000 
A r t e d . B y 
3r?" i b- Data Modified î ^ l t i p i i e r 
E l u t i o n 
Signal i : DADl A, Sig=365,8 Ref«=off 
RetTime Type Area Amt/Area ^Amount Grp Name 
I 126.16067 4.26466e-l 53.80323 OLAQ-olaquindox 
53.80323 
7
-655 MM 
T
°talB : 
Results obtained with enhanced inte9ff^°f^ 
vißibile 24/10/2000 14.40.13 Page 1 of 2 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 23 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Analyte: OLAQUINDOX 
Unit 
Sample code 
235694 
235699 
235712 
235767 
235787 
235793 
Result 1 
(mg/kg) 
4,23 
5,40 
1,67 
< 0,11 
1,91 
< 0,11 
Result 2 
(mg/kg) 
5,77 
5,37 
1,76 
<0,21 
1,86 
<0,21 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 24 
Annex 2 
CAN FAS 
I Development and Validation of HPLC-methods for the official control of 
•Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
245723 
245746 
245780 
245781 
245825 
245829 
Result 1 
(mg/kg) 
2,0 
5,7 
blank 
blank 
1,8 
6,0 
Result 2 
(mg/kg) 
2,1 
6,2 
blank 
blank 
1,7 
5,9 
2V 
CANFAS COLLABORAT/VE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
rw„/ > , • • 2é October- XOOJD 
Datels) of analysis: .f.... .Vr.r: 
Chromatographic conditions; 
• Column: 
• D As described in the method 
. mother: iœ.™..~.*:<.Z~. ï.1'. #!T.. 
• Mobile phase: 
• JS^As described in the method 
• D Other: - " 
• Flow-rate: /<.?..... ml/min 
• Injection volume: ..-£(?....u' 
• Retention time of olaquindox: .£?.?.. min 
C"" "» tmf»rmr Pff mur ft"*"*» représentative chromatograms oft 
Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
fiecflverv results; . 
• Percentage recovery: 11 % (m*AT> 
• Single / duplicate determinations: D single j/dupiicate 
• If duplicate, please give both percentages: J.L % and .P.... % 
• Spiking level:...~! mg/kg 
• 
:a M i e o ; \ n c v u t j n \ x \wi 
±m 
Injection Date 
Sample Name 
Acq. Operator 
Method 
Last changed 
26/10/00 14 .12 .05 
Location : Via l 1 
C:\HPCHEM\l\METHODS\IZS_ME~l\OLAQUTD.M 
26/10/00 13.00.32 by , 
(modified after loading) 
Qlaquindox canfas 
DAD1 A, Sig=380,4 Ref=550,100 (CANFAS\OLAQUI18.D) 
Norm. 
40 
30 
2 0 -
10 
\ \ 
j\ V 
O/*^ «'^dofi; 
co 
10 
- ^ 
External Standard Report 
Sorted By 
Calib. Data Modified 
Multiplier 
Dilution 
Retention Time 
26/10/00 12.09.03 
1.0000 
1.0000 
A g n a l 1: DAD1 A, Sig=380,4 Ref=550,100 
RetTime Sig Type Area Amt /Area Amount Grp Name 
[min] [niAU*s] tng/ul] 
•I- •I- • I — I -
8.189 1 BB 124.84376 2.27448e-2 2.83955 olaquidox 
Totals : 2.83955 
Results obtained with enhanced integrator! 
End of Report *** 
strument 1 26/10/00 14.23.07 
Page 1 of ! 
v...,:«. 
•^n iec t ion 
^ - ö 
e j e c t i Da te 
s a m p l e Name 
A c q - O p e r a t o r 
Method 
L a s t c h a n g e d 
2 6 / 1 0 / 0 0 1 3 . 1 7 . 3 3 
L o c a t i o n : V i a l 1 
-£*«Un f, It M " 
M i s s 
j -
C:\HPCHEM\1 \METH0DS\IZS_ME~1\0LAQÜTD'.M 
2 6 / 1 0 / 0 0 1 3 . 0 0 . 3 2 by Miss _ 
( m o d i f i e d a f t e r l o a d i n g ) 
o l a q u i n d o x c a n f a s 
Norm. 
DAD1 A, Sig=380,4 Ref=550,100 (CANFAS\0LAQUM4.D) 
I 
r 
20 A 
10 -J 
V>: 
O) 
E 
m 
L.<^v~ 
SB 
ID 
—^-Q 
r - t ^ - * - " ' " 
10 
_m!d 
Sort 
.
c
»Ub 
ed By 
External Standard Report 
1uit7\Data Modified D i
^ï i n e r 
Retention Time 
26/10/00 12.09.03 
1.0000 
1.0000 
^9»al 1
'- DAD1 A, Sig=380,4 Ref=550,100 
Amount Grp Name 
«•aas1--1 >— " - • -—I 
T
° t a i s . 
1
 » a r i t S o b t a i n e d w i t h e n h a n c e d i n t e g r a t o r ! 
n i n g s
 o r E r r o r s . 
i n 9 : C a l i b r a t e d compound(s ) n o t found 
o l a q u i d o x 
0.00000 
W, 
tlntu « n t 1
 2 6 / 1 0 / 0 0 1 3 . 2 8 . 3 4 Miss 
Page 1 o f 2 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 25 
Annex 2 
CAN FAS 
: 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
255696 
255728 
255742 
255782 
255814 
255819 
Result 1 
(mg/kg) 
4,88 
nd 
1,70 
1,70 
4,88 
nd 
Result 2 
(mg/kg) 
4,88 
nd 
1,70 
1,70 
4,86 
nd 
IS 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
he method . x 
Uaie-ft-.H.e'T.^.H?^ .?:?.°*.^?...sy+w. 
Date(s) of analysis: ?. .7..\?T..?.#?•?•• 
CfiromafngmphKLCQiiditiflfls: 
• Column: 
• J? As described in the method 
• a Other: 
• Mobile phase: 
• a As described in the ethod 
• a Other: 
• Flow-rate: 1 ml/min 
• Injection volume:...4.0...ul 
• Retention time of olaquindox: 5,33.. min 
• Blind positive feed samples 
• Blind blank feed s.imple 
Please indicate the ol.iquindoxpeak with an arrow 
Recovery rp^n)^ 
• Percentage recovery: .?./*. % 
• Single /duplicate determinations:*single 0 duplicate 
• If duplicate, please give both percentages: » a n 
• Spiking level: ...5T mgAg 
2-5/ 
Chromatogram for olaquindox study 
Feed n° 255696 
Chromatogram for olaquindox study 
O l " « * ' * 
a 
u 
c 
«S 
XI 
V. 
Q 
« 
J3 
Feed n° 255819 (Blank) 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 26 
Annex 2 
CAN FAS n 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Date of analysis: 7/12/00 
Analyte: I OLAQUINDOX 
Unit 
Sample code 
265743 
265749 
265755 
265763 
265764 
265768 
Result 1 
(mg/kg) 
1,6 
5,1 
0,1 
0,7 
0,1 
6,0 
Result 2 
(mg/kg) 
1,5 
4,8 
0,1 
1,2 
0,1 
5,3 
2i 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: 1.1 .'.X4 .ÖÜ. 
Chromatographic conditions: 
• Column: 
• As described in the method 
Sk\&liÇGit& .?^.?...?r. . ^ / ^ > : 2 j ^ ' W v v U-d* 
• Mobile phase: 
•y As described in the method 
• Other: 
• Flow-rate: ....'..'.-£ ml/min 
• Injection volume: .Jr&...\il 
• Retention time of olaquindox:.. /. P.. mm 
Chromatooramc- PbM.ua Inch»«- ».prgsentative chromatoqrams of: 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
flecovery results: 
• Percentage recovery:.'....% 
• Single/duplicate determinations: single duplicate 
• If duplicate, please give both percentages: .71 % and % 
• Spiking level: ...3..... mg/kg 
50A1 
rbsrrtoa f ^ > C^> 
1.2E+05 
OLAQUIN0812021.CH1 
2.0E+04 
0.0E+00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 [min] 
F i l e name : OLAQUIN0812021.CH1 
Info : 
50 Al 
V i a l * - 21 Rack # = 1 
I n j e c t i o n Date : 8-Dec-2000 20:15:20 
Curr. Date : 18-Dec-2000 16:49:54 
User : 
Group :' OLAQUIN 
Control Method : 
# Name RT Area[uV.Sec] Quantity 
1 olaquindox 9.917 303752.400 0.000 
Total Area of Peak = 303752.400 [uV.Sec] 
• » r%-- «nun 4e.inX4 I W M « 
^ ^ d ^ e - s > 
51A1 
liV 
3.0E+05 
2.5E+05J 
2.0E+05 
1.5E+05 
1.0E+05; 
~5.0E+04 
O.OE+00 
OLAQUIN0812025.CH1 
12.00 14.00 [min] 
2.00 4.00 
OLAQUIN0812025 CHX 
File name 
Info : 
51A1 
Vial # - 25 Rack # - *
 Q 2i:25:02 
injection Date s£Djc ^ „ 5 , 
curr. Date
 (: 18-Dec 
User : . 
Group : OLAQUIN 
Control Method : 
Peak Detection Not Available 
^-^nnn IRAQ-58. Paa« N'1/1 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 27 
Annex 2 
CANFAS 
| Development and Validation of HPLC-methods for the official control of 
iÇoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
| OLAQUINDOX | 
Unit 
Sample code 
275700 
275720 
275745 
275773 
275805 
275830 
Result 1 
(mg/kg) 
5,22 
not detectable 
2,05 
not detectable 
5,30 
1,81 
Result 2 
(mg/kg) 
5,34 
not detectable 
1,98 
not detectable 
5,56 
1,89 
^ 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
n . , , , . . 4 1 s t week 2000 
Date(s) of analysis: 
Chromatographic conditions: 
• Column: 
• jsTAs described in the method 
• D Other: 
• Mobile phase: 
• &As described in the method 
• D Other: 
• Flow-rate: ..P./.S.-Ai.^ml/min . d e p e n d i n g on t h e back p r e s s u r e o f t h e c o l u m n 
• Injection volume: ...5.P....UI . f ° r code number 2 7 5 7 7 3 ; 100 u l 
• Retention time of olaquindox:10-J.4nin 
Chromatnpramc- P I * * * « inclnffft r w t f l n t a t i v f t chromatoerams of: 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Recovery rp^ultr 
• Percentage recovery:.....!. % 
• Single / duplicate determinations: % single 0 duplicate 
• If duplicate, please give both percentages: % and % 
• Spiking level: 3 mg/kg 
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Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
295704 
295721 
295732 
295756 
295762 
295786 
Result 1 
(mg/kg) 
3,8 
3,8 
0 
0 
1,2 
1,3 
Result 2 
(mg/kg) 
3,7 
3,7 
0 
0 
1,3 
1,3 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: ^^:2:f...••..£..£?...<?...<».. 
Chromatographic conditions; 
• Column: 
• a As described in the method 
. brother: MQ^^.^^^y.^/.^..ZS.^m(tn...i...Cl^...A..S./JL. 
• Mobile phase: 
• fcfAs described in tfie method 
• D Other: 
• Flow-rate: .....4.t£.... ml/min 
• Injection volume: .i&(?...\A 
• Retention time of olaquindox: .of.i. min 
chrnmafoframr pi*««» fariudp representative chromatograms oft 
• Blind positive feed samples 
• Blind blank leed sample 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: % 
• Single / duplicate determinations: 0 single ÉTduplicate 
. If duplicate, please give both percentages: 0 . % and ±Q. % 
• Spiking level: ...3 mg/kg 
® 
Sample Name olaQUindOX 7211 
Sample Type: Unknown 
Vial: 32 
Injection*: 1 
Injection Votums 100,00 ui 
Run Time: 15,0 Minutes 
Sample Set Name: OLAQUINDOX 
0,014 
3 
< 
Acquired By: System 
Date Acquired: 16-11-200015:34:13 
Acq. Method Set Olaquindox 
Date Processed: 18-11-200018:03:28 
Processing Method: ' 'o laauidox18 11 00 
Proc. Chnl. Descr.: PDA 380,0 nm 
Cromatogram 
1 
Nam 
olaquindox 
RT 
5,973 
Area 
308140 
Height 
8855 
Amount 
1.947 
Unto 
ug/rrt (M^'^s) 
Report Method: c- itquindox Printed 11:20:52 05-12-2000 Page: 1 of 1 
Sample Name olaauindox 7321 / II 
Sampte Type: Unknown 
Vial: 34 
Injection #: 1 
Injection Volume- 100,00 ul 
RunTime: 15,0 Minutes 
Sample Set Name: olaauindox 2 
Acquired By: System 
OateAcquHwt 16-11-200018:01:25 
Acq. Method Set Olaquindox 
Date Processed; 18-11-200018:03:28 
Processing Method . olaauidox18 11 00 
Proa Chnl. Descr.: PDA 380,0 nm 
Cromatogram 
8.00 10,00 
1 r-
12,00 14,00 
Mnutes 
Report Method' , Olaquindox 
- p - ^ ^ 2 0 : « 05-12^000 Page: 1 of 1 
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Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Analyte: OLAQUINDOX 
Unit 
Sample code 
315707 
315709 
315710 
315794 
315801 
315811 
Result 1 
(mg/kg) 
0 
6,28 
1,88 
6,05 
0 
2,08 
Result 2 
(mg/kg) 
0 
6,13 
1,90 
5,86 
0 
1,80 
~b) 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 • OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: . . . » " J . U & Ä S ß . 
Chromatographic conditions; 
• Column: 
• » As described in the method 
• • Other: 
• Mobile phase: 
• B As described in the method 
• D Other: 
• Flowrate: ....1».$— ml/min 
• Injection volume: ...lG&.ul 
• Retention time of olaquindox: .^t & m i n 
Chromatogramfh Pf»«"» ' n c ' » d p »• nrpsftntative chromatograms oft 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
flecovflry results; 
• Percentage recovery: % 
- Single / duplicate determinations: • single 8 duplicate 
• If duplicate, please give both percentages: ^ K. % and .0&. % 
Spiking level:....5..... mg/kg 
• 
Software Version 
Sample Name 
Instrument Name 
Rack/Vial 
Sample Amount 
Cycle 
6.1.1.0.0:K20 
0022012-
HPLC-1 
0/0 
1,000000 
19 
H. 
Date 
Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
520} 
Page ,0! 
7-11-00 9:03:51 
6-11-00 20:19:35 
A 
1,000000' 
Result File : \\i J4s\TCDATAY J Residue\HPLC-1\olaquindox\061100-019.rst 
Sequence File : \\r . J04S\TCDATA\ . Residue\HPLC-1\olaquindox\testolx.seq 
f 
& -
No peaks available to report 
5,0 
Time [min) 
llll|llll|l!ll| 
Software Version : 6.1.1.0.0.K20 
Sa*" île Name : 0022010-
''• jment Name 
Rack/Vial 
Sample Amount 
Cycle 
HPLC-1 
0/0 
1,000000 
10 
Date 
Data Acquisition Time 
Channel 
Operator 
Dilution Factor 
7-11-00 9:02:51 
6-11-00 15:34:47 
A 
'1,000000 
Result File : Ui :004s\TCDATAV . Residue\HPLC-1\olaquindox\061100-010.rst 
Sequence File : \V «4s\TCDATA\. Residue\HPLC-1\olaquindox\testolx.seq 
I 
Time [min] i e 
peak Component Time Area Height Raw Amount Area/ 
* Name [min] [uV*se.c] [uV] Amount [Norm. %] Amount 
1
 7,353 176368 8792 176368 100,00 1.0000 
176368 8792 176368 100,00 1,0000 
Pagel 
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CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Coccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
325705 
325716 
325744 
325747 
325798 
325807 
Result 1 
(mg/kg) 
5,91 
2,06 
Negative 
5,63 
Negative 
2,07 
Result 2 
(mg/kg) 
5,92 
2,24 
Negative 
5,71 
Negative 
2,03 
32 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
Chromatographic conditions: 
• Column: 
• D As described in the method 
• xf Other Waters Symmetry, C18, 5 um, 4.6mmX250mm (Part N° WAT 054215) 
• Mobile phase: 
• g As described in the method 
• • Other 
• Flow-rate: 1.4,ml/min 
• Injection volume: 20 (ML) 
• Retention time of daquindox: 7.05 min 
Chromatoanm«: Ptaree IrrW* "»nresontative chrpmatQflram» of; 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the oiaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: 84.5 % 
• Single/duplicate determinations: D single» duplicate 
• lfduplicate.pleasegivebothpercentages:8l.99%and86.97% 
• Spiking level: 3 mg/kg 
Page 1 of 1 / ^ 2 ) 
y 
Data F i i e C:\HPCHEH\1\DATA\05122000\OLAQ0008.D Sample Name: 
&LQntL À&MÏLÉ 
I n j e c t i o n Date : 1 2 / 5 / 0 0 9 : 2 3 : 3 7 PH 
Sample Name : "* 
Acq. Operator : , .
 r 
Seq. Line : 8 
V i a l : 8 
I n j : 1 
I n j Volume : 20 u l 
Acq. Method 
Laat changed 
: C:\BPCHEH\l\HETHODS\OLAQUIN.H 
: 1 2 / 5 / 0 0 9 : 2 1 : 3 7 PH b y . 
( m o d i f i e d a f t e r l o a d i n g ) 
A n a l y s i s Hethod : C:\HPCHEH\l\HETHODS\OLAQUIN.H 
Las t changed : 1 2 / 6 / 0 0 1 2 : 2 3 : 1 1 PH b y 
( m o d i f i e d a f t e r l o a d i n g ) 
PE-032-mVUT, 
PAT054215,Paters. 
y symmetry, 250 x 4.6 mm, ref. 
DAD1 A. Si(p380.100 Ref=550.50 <P5122000\OLAQ0008.D) 
mAU 
g.a | m m s g n g i s s 
•¥&*—-£. *«*>
 |Cie | 0 g «j d g x; gj 
' " I I I I — I .II.,. 
JO. 
External Standard Report 
Sorted By 
Calib. Data Modified 
Hultiplier 
Dilution 
Signal 
12/6/00 12:23:08 PH 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig-380,100 Ref«550,50 
RetTime Type 
[min] 
1 
Area 
[mA0»s] 
•I 
Amt/Area Amount Grp Name 
[ug/ml] 
•I- •I—I-
6.923 W 10.86601 5.52238e-2 6.00063e-l 
Totals : 6.00063e-l 
Olaquindox 
Instrument 1 12/6/00 12:27:36 PH 
Page 1 of 
file:/A\Hp-q-4\printer\01aquindox2.gif 23-01-2001 
Data F i l e C:\HPCHEH\1\DATA\05122000\OLAQ0010.D 
Code 325705 , maasa - 2 5 . 0 0 4 9 g 
Page 1 of 1 
Sample Name: 325705/ 
a 
Injection Date : 12/5/00 9:57:44 PH 
Sample Name : 325705/ 
Acq. Operator : -
Acq. Hethod 
Last changed 
: C:\HPCHEH\1\HETHODS\ OLAQUIN. H 
: 12/5/00 9:55:42 PH by C 
(modified after loading) 
Analysis Hethod : C:\HPCHEH\l\HETHODS\OLAQUIN.H 
Last changed : 12/6/00 12:23:11 PH by 
(modified after loading) 
Seq. Line : 10 
Vial : 10 
Inj : 1 
Inj Volume : 20 ni 
PAT054215,Paters. 
,C, PE-032-HP/QT, Symmetry, 250 x 4.6»,
 ref. 
DAD1 A. Sifl-380.100 Ref-5S0.S0 (0S1220OO«3LAQO01O.D) 
«i« iffi 8 
, f l l" l l A •*• , » 
External Standard Report 
Sorted By 
Calib. Data Hodified 
Hultiplier 
Dilution 
Signal 
12/6/00 12:23:08 PH 
1.0000 
1.0000 
Signal 1: DAD1 A, Sig-380,100 Ref-550,50 
RetTime Type Area 
[min] [mAÜ*s] 
Arat/Area Amount Grp Name 
[ug/ml] 
1 1 —I 
7~034'HH '~ 51^71388 5.60974e-2 2.90101 Olaquindox 
Totals : 2.90101 
nstrument 1 12/6/00 12:30:28 PH Page 1 of 
Je:/AVHp-q-4\printer\01aquindox4.gif 23-01-2001 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 33 
Annex 2 
CANFAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Analyte: OLAQUINDOX 
Unit 
Sample code 
335702 
335706 
335753 
335759 
335772 
335804 
Result 1 
(mg/kg) 
<1 
2,3 
<1 
7
'
4 
7,2 
2,5 
Result 2 
(mg/kg) 
<1 
2,4 
<1 
6,9 
7,2 
2,5 
33 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: 
Chromatographic ™nrfitions: 
• Column: 
• E^ As described in the method 
• a Other: 
• Mobile phase: 
. o As described in the jnethod i I (j 
t / Other: % >wi / 5 ^ ?,. .<?. .1M. .*!Meó^&x£<k&S.f>. H. £.{... *.<£.(??*; W & . 
. Flovwate: ". £>*£..• m ' /m i n 
• Injection volume: ..^.ft—ul 
• Retention time of olaqumdox:.. ?.> I. mm 
^r^atngram^ Ptease inchtdft representative chromatograms of: 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Rffcovffry results: 
• Percentage recovery: 3.».-% 
. Single/duplicate determinations: D single ^duplicate 
. If duplicate, please give both percentages: M. % and .5 .1 % 
. Spiking level: ..4.0... mg/kg 
< & 
Sample Set Name OLA18 
User Name RVSA 
Current Date 18/10/00 
Current Tire 02:29:43 
Auto-Scaled Chrom atogram 
4,00 
SarrpleName 7842/00 
Peak Results 
1 
Name 
OLA 
RT 
2.683 
Area 
126856 
Height 
15667 
Amount 
7,239 
Units 
mg/kg 
Î 
Mu Wa4 =!3, 
Sanpte Set Name 0LA18 
User Narre RVSA 
Current Date 18/10/00 
Current Tire 02:29:38 
Auto-Scaled Chromatogram 
0.50 
2,00 2,50 
Minutes 
SampteName 7841/00 
3.00 3,50 4,00 
Peak Results 
3^; 
Sanpte Set Name OLA18 
User Name FVSA 
Current Date 18/10/00 
Current Time 02:29:34 
3 
< 
Auto-Scaled Chromatogram 
2,00 
Mnutes 
SarrpleName 7840/00 
4,00 
Peak Results 
I Name 
1 OLA 
RT 
2,685 
Area 
88628 
Height 
10323 
Amount 
2,495 
Units 
mg/kg 
t 
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Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
Analyte: OLAQUINDOX 
Unit 
Sample code 
345698 
345717 
345750 
345752 
345778 
345826 
Result 1 
(mg/kg) 
0 
1,5 
4,7 
1,5 
4,8 
0 
Result 2 
(mg/kg) 
0 
1,5 
4,8 
1,5 
4.9 
0 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 • Questionnaire 
Date(s) of analysis: , 
Chromatographic conditions; 
• Column.' 
• «f As described In the method 
• • Other: 
• Mobile phase: 
* jSCAs described in the method 
t a Other: 
• ftovHSto . . . . î^C.... . ml/Wfi 
• Injection volume: ...W?;...ul 
• Retention time of oiaqufndox: ..if.. w\n 
t f pfariv ehrnmatcgiamf-at 
t Blind positive feed samples 
. ßfind blank feed sample 
P/gtso Matt the c 
Rnnnvprv »»suite ## 
. Percentage recovery :«^* „>+**** 
.
 tf delicate, please ßlve both percentages: ^ . % and.* . . . . * 
. Spiking level: . . # • • • • - m s / k g 
(£9 
KromaSystem 2000 
Channel 2 
b'W*.l h\o*h 
KromaSystem 2000 Version 1.83 RESULT REPORT: INTEGRATION 
SYS2 - OLAQ025.SMP: Olaquindox-
No. 07: C1908" 25g/50ml 
Channel 2: DETECT 332 
No Text 
Enquete 
acquired : 30.10.00 13:01:45 
Processed: 15.11.00 11:06 
Program File OLAQ001 
Worksheet OLAQ 
Peak Table OLAQUIND 
Parameter Table .. OLAQUIND 
Report File 
Document File .... 
50.0 
37.5-
30.0-
22.5 
15.0-
7.5-
-3.a 
0.0 1.5 3.0 4.5 6.0 7.5 ä!o 10.5 12.0 14.0 
No. PNo Ret.Time Type 
min 
Name Area 
mV*mln 
Amount Rel.Ar 
% 
O.OOOOe+000 O.OOOOe+000 0.00 
Sample Report Page 1 of 1 Printed: 15.11.00 11:06 
C$> 
KromaSystem 2000 
Channel 2 
KromaSystem 2000 Version 1.83 RESULT REPORT: INTEGRATION 
SYS2 - OLAQ025.SMP (modified): Olaquindox 
No. 13: C1910" 25g/50ml Acquired 
Channel 2: DETECT 332 
No Text 
Program File OLAQ001 
Worksheet OLAQ 
Peak Table OLAQUIND 
Parameter Table .. OLAQUIND 
Report F i l e 
Document F i l e . . . . 
Enquete 
30 .10 .00 14:32:18 
Processed: 15 .11 .00 11-07 
50.0 
30.CH 
22.5H 
9.0 10.5 12.0 
No. PNo Ret.Time Type 
min 
Name 
7.83 MOD olaquindox 
Area 
mV*min 
Amount Rel.Ar 
t 
5.7859e+000 4.7822e+000 100.00 
5.7859e+000 4.7822e+000 100.00 
f 
Sample» Report 
Page 1 of 1 Printed: 1 5 . 1 1 . 0 0 11:0™ 
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08/12 '00 10:19 
Oloquindox in Teed 
Mod«: Reprocessed Data 
Original Results: C:\TSP\SYSTEMl\0ata\ola011200AMRES 
Reprocessed Rmcute: C:\TSP\6YSTEM1 \Data\ola011200AM.RMS 
A n a l y s i s R i p o r t 
Pagel 
Roportcd On: 07-12-00 1G:04:54 
Nam*'H 
Description: S 
Typa: Sample 
Injection Volume: S0.0 uL 
Acquisition Log 
Column Pressura (PSI): 2590 
Noise (microAU): 1e+02 
Run-Time Messages: None 
Viel: AZ8 injection: 1 of 1 
Injected On: 02-12-00 02:34:50 
Column Temperature (C): N/A 
Drift (mirrrvAI.I/min): -2»*02 
Pump Row Stability: 22. 
Signal 1 : LA/2000 A 380 run 
Calculation Type: External Standard (Height) 
mVormAU 
O Ol 
a, 
10.429 olaauindox ? 
ff 
S. 
12 
-o 
K 
Component 
olaquindaic 
Totals 
RT(mln) 
10.42e 
Area Height 
260546 78S2 
260545 7852 
ug/rnl Peak Typa 
1.7086 Modified 
1.7836 
S. 
f i f 
S 
I» 3 
3 
a 
ce 
O* 
2 
sa es. 
System: Reprocess Analyst AM 
Acquisition Method: C:\TSP\SYSTEM1\Metrwds\olaquindoxJVOM 
Calculation MeUmd. CATSr^MuUiutitfuliiq.CAM 
Report Method: CATSP\Methods\olaa.RPM 
PC1000 Ver 3.5.1 
29-11-00 18:31:34 
U4-1K-UU iu:iu:4ö 
IK-1MV11J-57-9A 
08/12 '00 10:20 
><?ï 
Olaquinriox in Feed 
Mode: Reprocessed Data 
unginai Results: C:\TSP\SYSTEMl\Data\ola011200AM.RES 
Reprocessed RcauHa: C:\TSP\3Y3TEMl\Data\ola0l lüUUAM.HMS 
A n a l y s i s R e p o r t 
Name: 10 
Description: 10 
Type: Sample 
Injection Volume- 50.0 ul. 
Vial:A92 
P B Q B 2 
Ropoitcd On: 07-12-00 10.34.34 
injection: 1 of 1 
Injected On: 02.12-00 03:40:08 
Acquisition Log 
Column Pressure (PSI): 2575 
Noise (mieroAU): 2e+02 
Run-Time Messages: None 
Column Temperature (C): N/A 
Drift (microAU/min): -d*+fl? 
Pump MOW Stability: Z2 
Signal 1 : UV2000 A 380 ran 
Calculation Type: External Standard (Height) 
mVormAU 
•*t 
Component 
Totals 
RT(min) Area 
o 
Height 
0 
ug/ml Peak Type 
0.0 
3 
'S 
n' 
£ 
3 
S 
o 
ira 
" i 
SB 
" I 
s 
X I 
S" 
CL e 
x 
Ana 
S S E ^ T S F ^ S T ^ m e t h o ^ c ^ K t o x A Q « 
Caicuraaon Method: U l i S ^ e t h o o * \ o ^ . C A M 
Rar«« Method: C.-\TSP\Methodc\olaq.RPM 
Analyst: AM PCI0O0 Ver 3.3.1 
20-11-00 1831 -M 
04-12-0018:10:48 
06-1SMKI 12ä /2B 
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Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
385726 
385737 
385783 
385789 
385803 
385815 
Result 1 
(mg/kg) 
6,00 
0 
1,72 
2,01 
0 
5,53 
Result 2 
(mg/kg) 
5,52 
0 
1,76 
1,94 
0 
5,38 
3<8 
CANFAS COLLABORATIVE STUDIES - OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: 11/27/00 
Chromatographic conditions: 
• Column: 
D As described in the method 
X Other: Hypersil ODS C-18,250 x 4,6 mm, 5 urn 
• Mobile phase: 
X As described in the method 
D Other: 
• Flow-rate: 1 ml/min 
• Injection volume: 20 M' 
• Retention time of Carbadox: 6 min 
Chromatoarams- Please iniiiude representative chromatograms of: 
• Blind positive feed samples 
• Blind blank samples 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: 81 % 
. Single/duplicate determinations: X single 0 duplicate 
. If duplicate, please give both percentages: ...% and ... % 
• Speaking level: 2 mg/kg 
(3K) 
CANFAS COLLABORATIVE STUDIES - OLAQUINDOX 
Remarks / Comments (if necessary, continue on another page): 
Please note that our detection system has been DAD; not a single wavelength UV-detection (as it has 
been indicated at particulary instruction) because we have not it. 
Chromatograms for standard (3 ppm), sample (385726) and blank 
DAD1 A, Sig=375,4 Ref=460,60 (LSPA\OLAQUM 
mAU 
8 -
6 -
4-
2-
0 — 
( 
\OLQX2003.D) 
in 
u> 
CO 
CO 
Olaquindox A 
3 2 4 
DAD1 A, Sig=375,4 Ref=460,60 (LSPAVOLAQUM' 
mAU -
8
~ 
6 -
4 -
2-
0 -
C 
1 | 
/ 
/ I f 1 
ƒ V 
___/ 
i ' • • i ) 2 4 . 
DAD1 A, Sig=375,4 Ref=460,60 (LSPA\OLAQUM' 
mAU
 : 
B-
6
": 
4
~ 
2-
0-
C 
I \ 
/ V 
/ \ 
/ v^ ^^  J 
2 4 
i ' ' • i ' i 
6 , 8 
AOLQX2012.D) 
CO 
CO 
6 8 
" *\OLQX2013.D) 
I * • • I — i r-
6 8 
rrtn 
mir 
—-~> 
min 
APPENDIX 6 
Table with results, questionnaire (page 1) and chromatograms 
of partner 40 
Annex 2 
CAN FAS 
Development and Validation of HPLC-methods for the official control of 
Çoccidiostats and Antibiotics used as Feed Additives (SMT4-CT98-2216) 
Subtitle: 
Lab-name: 
Contact person: 
Date of analysis: 
Analyte: 
Task 4 COLLABORATIVE STUDY 
e-mail: 
fax: 
telephone: 
OLAQUINDOX 
Unit 
Sample code 
405697 
405701 
405734 
405779 
405799 
405800 
Result 1 
(mg/kg) 
bianco 
bianco 
1,50 
4,75 
2,21 
5,20 
Result 2 
(mg/kg) 
bianco 
bianco 
1,80 
4,56 
1,62 
5,74 
MÖ 
C^FÄS COLLABpRÀtlVESTUDIESOCTOBER 200Q - OLÂQUINDOX 
'Annex 4 ••-. Qti#stionnaJre 
.. Datcf! tafs) of.analyCTs:..r^ ^^ 
• •Chrbmatogr^ Rir/rQriditiQOs:.' '/.•;.•• j . . . ; - ^ ;',/ ..••'....': (:-:;r, ••^••'{/'.,'"•/.. '..• ;•;' ;.....••.•'•'.''•'':"• 
;•'•••^•;Cplurnri^•v\':•:;;•v••JJ;'^::;^^••'j:'y^.^ ;••.•• ..."'•-.•.•. • '';-'. ••^.:y". •y;.::'.::'"';".-" .'!.'' :'..;' ".'•"•'.'••';'••: '"•.'•'!.-'• •.••'•'i-'•'•'.'.• •''•' 
/'^-'•'';•; Vi'Vb:'tó;'itócrïtó^ ;;'v:'.'.-;',: ••''.•'.•''•ƒ;;:'.'••:••;'..•;'• • '.'" -"'V'1 ••••.•'•'.•':•' 
:'••'""•.•Mpb'rfephase:'•':. .•'•'-•'•'.•'.•.'.:'',,:'-l'"".••>;"''•"•""• .•'•"'•••'••'•,;'.'.:'.'.','.• '.' ••• •'.' ••'.•'.'.:' 
r .V« ; aAsdesçnïedinthriTOftod^ • ••!:':••''•••''!''•.-".''"•'•.•'•'''••'••'•'-•'•'•'. " •' '' '•'••."'"'.'".•'•."••'••:'.•."'•;•'•". 
'•"•^ .•'. ' • .',' -OOthcn..;.....' .<•"'•;>••'•*."• '"""•"'", .••">.".;.;.;.?...«« 
••••'\-'injV^nnim!iimei;^«C'--'-.',';-: .'.•.•..•'/'.:'•• '.'.'':••• 
V '•' détentiontimeoifplaqüirido«..fh^..™h" •••• .•.••''.'..o'.;' 
• * • • • • » « ' « « * • . 
' '•••'• :Bfind posrbv«fëédsa'ihppltó' •• ','••;.'• ;'.'•'•"..•• '_/;'•'' •'•• •• :."';. •' ."• ' ;•'':[•;'.•••• y 
». BfîfidblankfeèdsaiTiplè: ' .;''*v"."--/."''•.• 
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APPENDIX 7 
Result of special requests 
of 
Masterlab, Putten, The Netherlands 
CANFAS COLLABORATIVE STUDIES OCTOBER 2 0 0 0 - OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s) of analysis: P.1.":A.?.7.?.S.9.?. 
Chromatographie conditions: 
• Column: 
• • As described in the method 
• o Other: 
• Mobile phase: 
• • As described in the method 
• n Other: 
• FlowH-ate:. i /..? m|/min 
• Injection volume: .?.9. uf 
• Retention time of olaquindox: &r .3 . min 
Chromatograms: Please include representative chromatn e ^ m 5 Oft 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Recovery results: 
• Percentage recovery: ?.?. /. P% 
• Single /duplicate determinations: o single • duplicate 
• If duplicate, please give both percentages: ?.7.rPu and3it.?. % 
• Spiking level: ....£ mg/kg 
Olaquindox 
Monster: 6 450558 
Instrument : UV_5 
M e t h o d e : i^.ml^ WOLI^ ATAVEIi^ AdmmVPn o^MUI^ ixlMlMcthoifOUqiuMloijBci 
Pile : \\Fi_mUb\VOLI\DATA\Elilc_Admiii\ProittuOI«iuii»)o»J>ili\nl»)iiii»la<-OI 1200013 
Sequence : \Js_mUb\V0LI\DATA\Ehle_Admin\Projtta>0U«lui~to»<S<«r«iict'Ol«qiiiii<ttr< m\ 
Gebruiker : asc 
Runtijdstip: 12-01-2000 18:52:21 
Inweeg : 24.9698 
Verdunning: 100 
Mihi pvjihhe fttd SÛM/P/Z, 
0.0050 -i 
0.0025 
0.0000 i 
-0.0025 
0 2 
sak: Olaquindox - ESTD - UV-Detect 
f 
0.0050 
0.0025 
0.0000 
-0.0025 
010006000800000 
Area 
UV-Detector 
Results 
Pk# 
Olaquindox 
Retention Tin» Area Height ESTD U n i t s 
concentration 
6.37 30387 1294 4.46817 mg/kg 
Olaquindox 
Monster: 1 450556 
Instmment : UV_5 
Methode : VIijiiU^VOLl\DATA^ilt_Aéma'VtqtaM>lÊifmim>Meù«tC»xrmtoxMtl 
F i l e : Wi_ml^>\VOL1\DATA\£lile_AdmiiiM>roj«ctlï3U<)uii»)o«lD»BW»)uil»lox_0l 1200.010 
Sequence : Wi_mUbWOLI\DATA\Elilc_A*nin\Pit>j«a«ï)l«)uiiKlo»lS«iiiaice'Otaiumdoijcq 
0.0050-
0.0025 
Gebruiker : asc 
Runtijdstip: 12-01-2000 17:34:56 
Inweeg : 25.4734 
Verdunning: 100 
0.0000 
•0.0025 
0 2 
jak: Olaquindox - ESTD - UV-Detect 
15 PP m 
0.0050 
0.0025 
0.0000 
-0.0025 
01000B000800000 
Area 
UV-Detector 
Results 
pk # Retention Time Area Height ESTD U n i t s 
concentration 
Olaquindox 0.00000 BDL mg/kg 
APPENDIX 7 
Result of special requests 
of 
National Veterinary Institute, Uppsala, Sweden 
CANFAS COLLABORATIVE STUDIES OCTOBER 2000 - OLAQUINDOX 
Annex 4 - Questionnaire 
Date(s)0fanalysis:. . . .P0.l ! . \ l : . /OO||2O 
Chromatographic conditions: 
• Column: 
• D As described in the method . 
.
 D other: ;.îfofe&.CSÎ.l .G.tè. <?A£..M& 2$Ç..*MfiÄ...J W*fc 
• Mobile phase: 
• J^As described in the method 
• D Other: 
• Flow-rate: ...J.j..0 ml/min 
• Injection volume: ...v!W...pl 
• Retention time of olaquindox: XiQ. min 
Çhromatograms: Please include representative chromatograms pf; 
• Blind positive feed samples 
• Blind blank feed sample 
Please indicate the olaquindox peak with an arrow 
Recovery results; . 
• Percentage recovery: .7>/v. % 
• Single / duplicate determinations: • single Jrfjuplicate 
• If duplicate, please give both percentages: *}.>?/% and ÎUÊ».. % 
• Spiking level: ^ . Ï L mg/kg 
******* 
EXTERNAL STANDARD TABLE 
******* 
* 
* Dat 
************* 11-20^2000 no. —- in v i s i o n 5.1 
***** - • « Data F i l e 
* * * * * * * 
* * * * * * * * * * * * * * * * * * * * * * 
D : B A Y O 0 5 1 v n r 1 • J jjetLct r u e : u : c f t i m i 3 iSample Name: pro - 5 . 0 i , : -2 4 M e t l iod : D^ BAYONOX 11-20-2000 09:26:09 # 222 
a e : 1 1 - i y - ^ u u u _  _^ ^ n n B r a f n r a n n C h a n n e l « : 0 V i a l t t : * interface: 0 Cycle« 1 Oper to hannel# Vial# 
xxx—r _ w-Mth- 15 Threshold: 1 Area Threshold: 200 * 
* starting PeaK wi"L •^
 + Jt + + *********************************************** 
********************oo - Ending retention time 
One sample per 0.2 00 sec 
Dilution factor 
Starting Delay: 
Area reject: 
Amount injected 
Sample Weight: 
PEAK RET PEAK 
NUM TIME NAME 
200 50.00 
1.00000 
15.00 
ÎC. 
1.00 
CONCENTRATION in 
ug/ml 
NORMALIZED 
CONC 
AREA/ 
HEIGHT HEIGHT BL 
REF 
PEAK 
% DELTA 
RET TIME CONC/AREA 
TOTAL AMOUNT 
0.0000 
NAME 7 .77 
bayo 
REFERENCE PEAK 
bayo 
A v^ -irrhts stored in: D:BAYO051 .ATB 
Areas, times, ^ _£?} gi£| Printed on 11-20-2000 at 09:27:12 
Data File = D:BAYO051 .PTS *T ^ ^
 1 5 > Q 0 min_ offset: 
Start time: °„U,„ 'Hiah Value: 133401 uv Scale factor: 
Low Value: ° u v n a 
0 mv. 
5.0 
bM H 
******* EXTERNAL STANDARD TABLE ******* 
******************** 12-05-20no 14:00:3,0 Version 5.1 ********************** 
* Sample Name : prov nr 5 F Data File: D:BAYO04 7 
* Date: 11-19-2000 14 :12 huweuiuu: LCbAiTONOX 12-05-2000 13:59:28 # 235* 
* Interface: 0 Cycle#: 1 Operator ann Channel#: 0 Vial#: * 
* Starting Peak Width: 15 Threshold: 1 Area Threshold: 200 * 
*************************************************************************** 
Starting Delay: 0.00 Ending retention time: 15.00 
Area reject: 200 One sample per 0.200 sec. 
Amount injected: 50.00 Dilution factor: 1.00 
Sample Weight: 1.00000 
PEAK 
NUM 
1 
RET 
TIME 
7.774 
PEAK CONCENTRATION in 
NAME ug/ml 
bayo 0.424 9 
TOTAL AMOUNT - 0.4249 
NORMALIZED 
CONC 
100.0000* 
AREA 
28933 
AREA/ 
HEIGHT HEIGHT BL 
1G89 17.1 1 
REF 
PEAK 
1 
* DELTA 
RET TIME 
0 
CONC/AREA 
1.4684E-05 
Areas, times, and heights stored in: D:BAYO04 7.ATB 
I^a File = D:BAYO047. PTS Printed on 12-05-2000 at 14:00:32 
Start time: 0.00 min. Stop time: 15.00 min. Offset: 
Low Value: 0 uv High Value: 47888 uv Scale factor: 
0 mv. 
5.0 
Z pprn. Sample 
»matograms of: 
M. % 
